<html lang="en">
 <head>
  <meta charset="utf-8"/>
  <meta content="IE=edge" http-equiv="X-UA-Compatible"/>
  <meta content="width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no,viewport-fit=cover" name="viewport"/>
  <!--[if IE]><link rel="icon" href="/favicon.ico"/><![endif]-->
  <link as="font" crossorigin="" href="../../../fonts/Rotunda-Bold.95058a64.woff2" rel="preload"/>
  <link as="font" crossorigin="" href="../../../fonts/Rotunda-Medium.58dbc1ef.woff2" rel="preload"/>
  <link as="font" crossorigin="" href="../../../fonts/Rotunda-Regular.df81003c.woff2" rel="preload"/>
  <title>
   Shortform | An American Sickness
  </title>
  <style type="text/css">
   .vue-slider-dot{position:absolute;-webkit-transition:all 0s;transition:all 0s;z-index:5}.vue-slider-dot:focus{outline:none}.vue-slider-dot-tooltip{position:absolute;visibility:hidden}.vue-slider-dot-hover:hover .vue-slider-dot-tooltip,.vue-slider-dot-tooltip-show{visibility:visible}.vue-slider-dot-tooltip-top{top:-10px;left:50%;-webkit-transform:translate(-50%,-100%);transform:translate(-50%,-100%)}.vue-slider-dot-tooltip-bottom{bottom:-10px;left:50%;-webkit-transform:translate(-50%,100%);transform:translate(-50%,100%)}.vue-slider-dot-tooltip-left{left:-10px;top:50%;-webkit-transform:translate(-100%,-50%);transform:translate(-100%,-50%)}.vue-slider-dot-tooltip-right{right:-10px;top:50%;-webkit-transform:translate(100%,-50%);transform:translate(100%,-50%)}
  </style>
  <style type="text/css">
   .vue-slider-marks{position:relative;width:100%;height:100%}.vue-slider-mark{position:absolute;z-index:1}.vue-slider-ltr .vue-slider-mark,.vue-slider-rtl .vue-slider-mark{width:0;height:100%;top:50%}.vue-slider-ltr .vue-slider-mark-step,.vue-slider-rtl .vue-slider-mark-step{top:0}.vue-slider-ltr .vue-slider-mark-label,.vue-slider-rtl .vue-slider-mark-label{top:100%;margin-top:10px}.vue-slider-ltr .vue-slider-mark{-webkit-transform:translate(-50%,-50%);transform:translate(-50%,-50%)}.vue-slider-ltr .vue-slider-mark-step{left:0}.vue-slider-ltr .vue-slider-mark-label{left:50%;-webkit-transform:translateX(-50%);transform:translateX(-50%)}.vue-slider-rtl .vue-slider-mark{-webkit-transform:translate(50%,-50%);transform:translate(50%,-50%)}.vue-slider-rtl .vue-slider-mark-step{right:0}.vue-slider-rtl .vue-slider-mark-label{right:50%;-webkit-transform:translateX(50%);transform:translateX(50%)}.vue-slider-btt .vue-slider-mark,.vue-slider-ttb .vue-slider-mark{width:100%;height:0;left:50%}.vue-slider-btt .vue-slider-mark-step,.vue-slider-ttb .vue-slider-mark-step{left:0}.vue-slider-btt .vue-slider-mark-label,.vue-slider-ttb .vue-slider-mark-label{left:100%;margin-left:10px}.vue-slider-btt .vue-slider-mark{-webkit-transform:translate(-50%,50%);transform:translate(-50%,50%)}.vue-slider-btt .vue-slider-mark-step{top:0}.vue-slider-btt .vue-slider-mark-label{top:50%;-webkit-transform:translateY(-50%);transform:translateY(-50%)}.vue-slider-ttb .vue-slider-mark{-webkit-transform:translate(-50%,-50%);transform:translate(-50%,-50%)}.vue-slider-ttb .vue-slider-mark-step{bottom:0}.vue-slider-ttb .vue-slider-mark-label{bottom:50%;-webkit-transform:translateY(50%);transform:translateY(50%)}.vue-slider-mark-label,.vue-slider-mark-step{position:absolute}
  </style>
  <style type="text/css">
   .vue-slider{position:relative;-webkit-box-sizing:content-box;box-sizing:content-box;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;display:block;-webkit-tap-highlight-color:rgba(0,0,0,0)}.vue-slider-rail{position:relative;width:100%;height:100%;-webkit-transition-property:width,height,left,right,top,bottom;transition-property:width,height,left,right,top,bottom}.vue-slider-process{position:absolute;z-index:1}
  </style>
  <link data-vue-router-controlled="" href="https://www.shortform.com/app/book/an-american-sickness/chapter-4" id="canonical" rel="canonical"/>
  <meta content="A+N5HpM5gDAUeupaWw3J2yuMrpgH0IC7KtFHAqtmHkW8Vr+dPpJWuOpMNIRh3ybxyoIUKlvDQs7+VGPfYdQ/qQUAAABxeyJvcmlnaW4iOiJodHRwczovL2FjY291bnRzLmdvb2dsZS5jb206NDQzIiwiZmVhdHVyZSI6IkZlZENtQXV0b1JlYXV0aG4iLCJleHBpcnkiOjE2OTE1MzkxOTksImlzVGhpcmRQYXJ0eSI6dHJ1ZX0=" http-equiv="origin-trial"/>
  <style id="googleidentityservice_button_styles">
   .qJTHM{-webkit-user-select:none;color:#202124;direction:ltr;-webkit-touch-callout:none;font-family:"Roboto-Regular",arial,sans-serif;-webkit-font-smoothing:antialiased;font-weight:400;margin:0;overflow:hidden;-webkit-text-size-adjust:100%}.ynRLnc{left:-9999px;position:absolute;top:-9999px}.L6cTce{display:none}.bltWBb{word-break:break-all}.hSRGPd{color:#1a73e8;cursor:pointer;font-weight:500;text-decoration:none}.Bz112c-W3lGp{height:16px;width:16px}.Bz112c-E3DyYd{height:20px;width:20px}.Bz112c-r9oPif{height:24px;width:24px}.Bz112c-uaxL4e{-webkit-border-radius:10px;border-radius:10px}.LgbsSe-Bz112c{display:block}.S9gUrf-YoZ4jf,.S9gUrf-YoZ4jf *{border:none;margin:0;padding:0}.fFW7wc-ibnC6b>.aZ2wEe>div{border-color:#4285f4}.P1ekSe-ZMv3u>div:nth-child(1){background-color:#1a73e8!important}.P1ekSe-ZMv3u>div:nth-child(2),.P1ekSe-ZMv3u>div:nth-child(3){background-image:linear-gradient(to right,rgba(255,255,255,.7),rgba(255,255,255,.7)),linear-gradient(to right,#1a73e8,#1a73e8)!important}.haAclf{display:inline-block}.nsm7Bb-HzV7m-LgbsSe{-webkit-border-radius:4px;border-radius:4px;-webkit-box-sizing:border-box;box-sizing:border-box;-webkit-transition:background-color .218s,border-color .218s;transition:background-color .218s,border-color .218s;-webkit-user-select:none;-webkit-appearance:none;background-color:#fff;background-image:none;border:1px solid #dadce0;color:#3c4043;cursor:pointer;font-family:"Google Sans",arial,sans-serif;font-size:14px;height:40px;letter-spacing:0.25px;outline:none;overflow:hidden;padding:0 12px;position:relative;text-align:center;vertical-align:middle;white-space:nowrap;width:auto}@media screen and (-ms-high-contrast:active){.nsm7Bb-HzV7m-LgbsSe{border:2px solid windowText;color:windowText}}.nsm7Bb-HzV7m-LgbsSe.pSzOP-SxQuSe{font-size:14px;height:32px;letter-spacing:0.25px;padding:0 10px}.nsm7Bb-HzV7m-LgbsSe.purZT-SxQuSe{font-size:11px;height:20px;letter-spacing:0.3px;padding:0 8px}.nsm7Bb-HzV7m-LgbsSe.Bz112c-LgbsSe{padding:0;width:40px}.nsm7Bb-HzV7m-LgbsSe.Bz112c-LgbsSe.pSzOP-SxQuSe{width:32px}.nsm7Bb-HzV7m-LgbsSe.Bz112c-LgbsSe.purZT-SxQuSe{width:20px}.nsm7Bb-HzV7m-LgbsSe.JGcpL-RbRzK{-webkit-border-radius:20px;border-radius:20px}.nsm7Bb-HzV7m-LgbsSe.JGcpL-RbRzK.pSzOP-SxQuSe{-webkit-border-radius:16px;border-radius:16px}.nsm7Bb-HzV7m-LgbsSe.JGcpL-RbRzK.purZT-SxQuSe{-webkit-border-radius:10px;border-radius:10px}.nsm7Bb-HzV7m-LgbsSe.MFS4be-Ia7Qfc{border:none;color:#fff}.nsm7Bb-HzV7m-LgbsSe.MFS4be-v3pZbf-Ia7Qfc{background-color:#1a73e8}.nsm7Bb-HzV7m-LgbsSe.MFS4be-JaPV2b-Ia7Qfc{background-color:#202124;color:#e8eaed}.nsm7Bb-HzV7m-LgbsSe .nsm7Bb-HzV7m-LgbsSe-Bz112c{height:18px;margin-right:8px;min-width:18px;width:18px}.nsm7Bb-HzV7m-LgbsSe.pSzOP-SxQuSe .nsm7Bb-HzV7m-LgbsSe-Bz112c{height:14px;min-width:14px;width:14px}.nsm7Bb-HzV7m-LgbsSe.purZT-SxQuSe .nsm7Bb-HzV7m-LgbsSe-Bz112c{height:10px;min-width:10px;width:10px}.nsm7Bb-HzV7m-LgbsSe.jVeSEe .nsm7Bb-HzV7m-LgbsSe-Bz112c{margin-left:8px;margin-right:-4px}.nsm7Bb-HzV7m-LgbsSe.Bz112c-LgbsSe .nsm7Bb-HzV7m-LgbsSe-Bz112c{margin:0;padding:10px}.nsm7Bb-HzV7m-LgbsSe.Bz112c-LgbsSe.pSzOP-SxQuSe .nsm7Bb-HzV7m-LgbsSe-Bz112c{padding:8px}.nsm7Bb-HzV7m-LgbsSe.Bz112c-LgbsSe.purZT-SxQuSe .nsm7Bb-HzV7m-LgbsSe-Bz112c{padding:4px}.nsm7Bb-HzV7m-LgbsSe .nsm7Bb-HzV7m-LgbsSe-Bz112c-haAclf{-webkit-border-top-left-radius:3px;border-top-left-radius:3px;-webkit-border-bottom-left-radius:3px;border-bottom-left-radius:3px;display:-webkit-box;display:-webkit-flex;display:flex;justify-content:center;-webkit-align-items:center;align-items:center;background-color:#fff;height:36px;margin-left:-10px;margin-right:12px;min-width:36px;width:36px}.nsm7Bb-HzV7m-LgbsSe .nsm7Bb-HzV7m-LgbsSe-Bz112c-haAclf .nsm7Bb-HzV7m-LgbsSe-Bz112c,.nsm7Bb-HzV7m-LgbsSe.Bz112c-LgbsSe .nsm7Bb-HzV7m-LgbsSe-Bz112c-haAclf .nsm7Bb-HzV7m-LgbsSe-Bz112c{margin:0;padding:0}.nsm7Bb-HzV7m-LgbsSe.pSzOP-SxQuSe .nsm7Bb-HzV7m-LgbsSe-Bz112c-haAclf{height:28px;margin-left:-8px;margin-right:10px;min-width:28px;width:28px}.nsm7Bb-HzV7m-LgbsSe.purZT-SxQuSe .nsm7Bb-HzV7m-LgbsSe-Bz112c-haAclf{height:16px;margin-left:-6px;margin-right:8px;min-width:16px;width:16px}.nsm7Bb-HzV7m-LgbsSe.Bz112c-LgbsSe .nsm7Bb-HzV7m-LgbsSe-Bz112c-haAclf{-webkit-border-radius:3px;border-radius:3px;margin-left:2px;margin-right:0;padding:0}.nsm7Bb-HzV7m-LgbsSe.JGcpL-RbRzK .nsm7Bb-HzV7m-LgbsSe-Bz112c-haAclf{-webkit-border-radius:18px;border-radius:18px}.nsm7Bb-HzV7m-LgbsSe.pSzOP-SxQuSe.JGcpL-RbRzK .nsm7Bb-HzV7m-LgbsSe-Bz112c-haAclf{-webkit-border-radius:14px;border-radius:14px}.nsm7Bb-HzV7m-LgbsSe.purZT-SxQuSe.JGcpL-RbRzK .nsm7Bb-HzV7m-LgbsSe-Bz112c-haAclf{-webkit-border-radius:8px;border-radius:8px}.nsm7Bb-HzV7m-LgbsSe .nsm7Bb-HzV7m-LgbsSe-bN97Pc-sM5MNb{display:-webkit-box;display:-webkit-flex;display:flex;-webkit-align-items:center;align-items:center;-webkit-flex-direction:row;flex-direction:row;justify-content:space-between;-webkit-flex-wrap:nowrap;flex-wrap:nowrap;height:100%;position:relative;width:100%}.nsm7Bb-HzV7m-LgbsSe .oXtfBe-l4eHX{justify-content:center}.nsm7Bb-HzV7m-LgbsSe .nsm7Bb-HzV7m-LgbsSe-BPrWId{-webkit-flex-grow:1;flex-grow:1;font-family:"Google Sans",arial,sans-serif;font-weight:500;overflow:hidden;text-overflow:ellipsis;vertical-align:top}.nsm7Bb-HzV7m-LgbsSe.purZT-SxQuSe .nsm7Bb-HzV7m-LgbsSe-BPrWId{font-weight:300}.nsm7Bb-HzV7m-LgbsSe .oXtfBe-l4eHX .nsm7Bb-HzV7m-LgbsSe-BPrWId{-webkit-flex-grow:0;flex-grow:0}.nsm7Bb-HzV7m-LgbsSe .nsm7Bb-HzV7m-LgbsSe-MJoBVe{-webkit-transition:background-color .218s;transition:background-color .218s;bottom:0;left:0;position:absolute;right:0;top:0}.nsm7Bb-HzV7m-LgbsSe:hover,.nsm7Bb-HzV7m-LgbsSe:focus{-webkit-box-shadow:none;box-shadow:none;border-color:#d2e3fc;outline:none}.nsm7Bb-HzV7m-LgbsSe:hover .nsm7Bb-HzV7m-LgbsSe-MJoBVe,.nsm7Bb-HzV7m-LgbsSe:focus .nsm7Bb-HzV7m-LgbsSe-MJoBVe{background:rgba(66,133,244,.04)}.nsm7Bb-HzV7m-LgbsSe:active .nsm7Bb-HzV7m-LgbsSe-MJoBVe{background:rgba(66,133,244,.1)}.nsm7Bb-HzV7m-LgbsSe.MFS4be-Ia7Qfc:hover .nsm7Bb-HzV7m-LgbsSe-MJoBVe,.nsm7Bb-HzV7m-LgbsSe.MFS4be-Ia7Qfc:focus .nsm7Bb-HzV7m-LgbsSe-MJoBVe{background:rgba(255,255,255,.24)}.nsm7Bb-HzV7m-LgbsSe.MFS4be-Ia7Qfc:active .nsm7Bb-HzV7m-LgbsSe-MJoBVe{background:rgba(255,255,255,.32)}.nsm7Bb-HzV7m-LgbsSe .n1UuX-DkfjY{-webkit-border-radius:50%;border-radius:50%;display:-webkit-box;display:-webkit-flex;display:flex;height:20px;margin-left:-4px;margin-right:8px;min-width:20px;width:20px}.nsm7Bb-HzV7m-LgbsSe.jVeSEe .nsm7Bb-HzV7m-LgbsSe-BPrWId{font-family:"Roboto";font-size:12px;text-align:left}.nsm7Bb-HzV7m-LgbsSe.jVeSEe .nsm7Bb-HzV7m-LgbsSe-BPrWId .ssJRIf,.nsm7Bb-HzV7m-LgbsSe.jVeSEe .nsm7Bb-HzV7m-LgbsSe-BPrWId .K4efff .fmcmS{overflow:hidden;text-overflow:ellipsis}.nsm7Bb-HzV7m-LgbsSe.jVeSEe .nsm7Bb-HzV7m-LgbsSe-BPrWId .K4efff{display:-webkit-box;display:-webkit-flex;display:flex;-webkit-align-items:center;align-items:center;color:#5f6368;fill:#5f6368;font-size:11px;font-weight:400}.nsm7Bb-HzV7m-LgbsSe.jVeSEe.MFS4be-Ia7Qfc .nsm7Bb-HzV7m-LgbsSe-BPrWId .K4efff{color:#e8eaed;fill:#e8eaed}.nsm7Bb-HzV7m-LgbsSe.jVeSEe .nsm7Bb-HzV7m-LgbsSe-BPrWId .K4efff .Bz112c{height:18px;margin:-3px -3px -3px 2px;min-width:18px;width:18px}.nsm7Bb-HzV7m-LgbsSe.jVeSEe .nsm7Bb-HzV7m-LgbsSe-Bz112c-haAclf{-webkit-border-top-left-radius:0;border-top-left-radius:0;-webkit-border-bottom-left-radius:0;border-bottom-left-radius:0;-webkit-border-top-right-radius:3px;border-top-right-radius:3px;-webkit-border-bottom-right-radius:3px;border-bottom-right-radius:3px;margin-left:12px;margin-right:-10px}.nsm7Bb-HzV7m-LgbsSe.jVeSEe.JGcpL-RbRzK .nsm7Bb-HzV7m-LgbsSe-Bz112c-haAclf{-webkit-border-radius:18px;border-radius:18px}.L5Fo6c-sM5MNb{border:0;display:block;left:0;position:relative;top:0}.L5Fo6c-bF1uUb{-webkit-border-radius:4px;border-radius:4px;bottom:0;cursor:pointer;left:0;position:absolute;right:0;top:0}.L5Fo6c-bF1uUb:focus{border:none;outline:none}sentinel{}
  </style>
  <style id="annotator-dynamic-style" type="text/css">
   .annotator-adder, .annotator-outer, .annotator-notice {
  z-index: 1040;
}
.annotator-filter {
  z-index: 1030;
}
  </style>
  <link href="https://a.omappapi.com/app/js/api.min.css" id="omapi-css" media="all" rel="stylesheet"/>
  <meta content="AymqwRC7u88Y4JPvfIF2F37QKylC04248hLCdJAsh8xgOfe/dVJPV3XS3wLFca1ZMVOtnBfVjaCMTVudWM//5g4AAAB7eyJvcmlnaW4iOiJodHRwczovL3d3dy5nb29nbGV0YWdtYW5hZ2VyLmNvbTo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjk1MTY3OTk5LCJpc1RoaXJkUGFydHkiOnRydWV9" http-equiv="origin-trial"/>
  <style data-fbcssmodules="css:fb.css.base css:fb.css.dialog css:fb.css.iframewidget css:fb.css.customer_chat_plugin_iframe" type="text/css">
   .fb_hidden{position:absolute;top:-10000px;z-index:10001}.fb_reposition{overflow:hidden;position:relative}.fb_invisible{display:none}.fb_reset{background:none;border:0;border-spacing:0;color:#000;cursor:auto;direction:ltr;font-family:'lucida grande', tahoma, verdana, arial, sans-serif;font-size:11px;font-style:normal;font-variant:normal;font-weight:normal;letter-spacing:normal;line-height:1;margin:0;overflow:visible;padding:0;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;visibility:visible;white-space:normal;word-spacing:normal}.fb_reset>div{overflow:hidden}@keyframes fb_transform{from{opacity:0;transform:scale(.95)}to{opacity:1;transform:scale(1)}}.fb_animate{animation:fb_transform .3s forwards}
.fb_hidden{position:absolute;top:-10000px;z-index:10001}.fb_reposition{overflow:hidden;position:relative}.fb_invisible{display:none}.fb_reset{background:none;border:0;border-spacing:0;color:#000;cursor:auto;direction:ltr;font-family:'lucida grande', tahoma, verdana, arial, sans-serif;font-size:11px;font-style:normal;font-variant:normal;font-weight:normal;letter-spacing:normal;line-height:1;margin:0;overflow:visible;padding:0;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;visibility:visible;white-space:normal;word-spacing:normal}.fb_reset>div{overflow:hidden}@keyframes fb_transform{from{opacity:0;transform:scale(.95)}to{opacity:1;transform:scale(1)}}.fb_animate{animation:fb_transform .3s forwards}
.fb_dialog{background:rgba(82, 82, 82, .7);position:absolute;top:-10000px;z-index:10001}.fb_dialog_advanced{border-radius:8px;padding:10px}.fb_dialog_content{background:#fff;color:#373737}.fb_dialog_close_icon{background:url(https://connect.facebook.net/rsrc.php/v3/yq/r/IE9JII6Z1Ys.png) no-repeat scroll 0 0 transparent;cursor:pointer;display:block;height:15px;position:absolute;right:18px;top:17px;width:15px}.fb_dialog_mobile .fb_dialog_close_icon{left:5px;right:auto;top:5px}.fb_dialog_padding{background-color:transparent;position:absolute;width:1px;z-index:-1}.fb_dialog_close_icon:hover{background:url(https://connect.facebook.net/rsrc.php/v3/yq/r/IE9JII6Z1Ys.png) no-repeat scroll 0 -15px transparent}.fb_dialog_close_icon:active{background:url(https://connect.facebook.net/rsrc.php/v3/yq/r/IE9JII6Z1Ys.png) no-repeat scroll 0 -30px transparent}.fb_dialog_iframe{line-height:0}.fb_dialog_content .dialog_title{background:#6d84b4;border:1px solid #365899;color:#fff;font-size:14px;font-weight:bold;margin:0}.fb_dialog_content .dialog_title>span{background:url(https://connect.facebook.net/rsrc.php/v3/yd/r/Cou7n-nqK52.gif) no-repeat 5px 50%;float:left;padding:5px 0 7px 26px}body.fb_hidden{height:100%;left:0;margin:0;overflow:visible;position:absolute;top:-10000px;transform:none;width:100%}.fb_dialog.fb_dialog_mobile.loading{background:url(https://connect.facebook.net/rsrc.php/v3/ya/r/3rhSv5V8j3o.gif) white no-repeat 50% 50%;min-height:100%;min-width:100%;overflow:hidden;position:absolute;top:0;z-index:10001}.fb_dialog.fb_dialog_mobile.loading.centered{background:none;height:auto;min-height:initial;min-width:initial;width:auto}.fb_dialog.fb_dialog_mobile.loading.centered #fb_dialog_loader_spinner{width:100%}.fb_dialog.fb_dialog_mobile.loading.centered .fb_dialog_content{background:none}.loading.centered #fb_dialog_loader_close{clear:both;color:#fff;display:block;font-size:18px;padding-top:20px}#fb-root #fb_dialog_ipad_overlay{background:rgba(0, 0, 0, .4);bottom:0;left:0;min-height:100%;position:absolute;right:0;top:0;width:100%;z-index:10000}#fb-root #fb_dialog_ipad_overlay.hidden{display:none}.fb_dialog.fb_dialog_mobile.loading iframe{visibility:hidden}.fb_dialog_mobile .fb_dialog_iframe{position:sticky;top:0}.fb_dialog_content .dialog_header{background:linear-gradient(from(#738aba), to(#2c4987));border-bottom:1px solid;border-color:#043b87;box-shadow:white 0 1px 1px -1px inset;color:#fff;font:bold 14px Helvetica, sans-serif;text-overflow:ellipsis;text-shadow:rgba(0, 30, 84, .296875) 0 -1px 0;vertical-align:middle;white-space:nowrap}.fb_dialog_content .dialog_header table{height:43px;width:100%}.fb_dialog_content .dialog_header td.header_left{font-size:12px;padding-left:5px;vertical-align:middle;width:60px}.fb_dialog_content .dialog_header td.header_right{font-size:12px;padding-right:5px;vertical-align:middle;width:60px}.fb_dialog_content .touchable_button{background:linear-gradient(from(#4267B2), to(#2a4887));background-clip:padding-box;border:1px solid #29487d;border-radius:3px;display:inline-block;line-height:18px;margin-top:3px;max-width:85px;padding:4px 12px;position:relative}.fb_dialog_content .dialog_header .touchable_button input{background:none;border:none;color:#fff;font:bold 12px Helvetica, sans-serif;margin:2px -12px;padding:2px 6px 3px 6px;text-shadow:rgba(0, 30, 84, .296875) 0 -1px 0}.fb_dialog_content .dialog_header .header_center{color:#fff;font-size:16px;font-weight:bold;line-height:18px;text-align:center;vertical-align:middle}.fb_dialog_content .dialog_content{background:url(https://connect.facebook.net/rsrc.php/v3/y9/r/jKEcVPZFk-2.gif) no-repeat 50% 50%;border:1px solid #4a4a4a;border-bottom:0;border-top:0;height:150px}.fb_dialog_content .dialog_footer{background:#f5f6f7;border:1px solid #4a4a4a;border-top-color:#ccc;height:40px}#fb_dialog_loader_close{float:left}.fb_dialog.fb_dialog_mobile .fb_dialog_close_icon{visibility:hidden}#fb_dialog_loader_spinner{animation:rotateSpinner 1.2s linear infinite;background-color:transparent;background-image:url(https://connect.facebook.net/rsrc.php/v3/yD/r/t-wz8gw1xG1.png);background-position:50% 50%;background-repeat:no-repeat;height:24px;width:24px}@keyframes rotateSpinner{0%{transform:rotate(0deg)}100%{transform:rotate(360deg)}}
.fb_iframe_widget{display:inline-block;position:relative}.fb_iframe_widget span{display:inline-block;position:relative;text-align:justify}.fb_iframe_widget iframe{position:absolute}.fb_iframe_widget_fluid_desktop,.fb_iframe_widget_fluid_desktop span,.fb_iframe_widget_fluid_desktop iframe{max-width:100%}.fb_iframe_widget_fluid_desktop iframe{min-width:220px;position:relative}.fb_iframe_widget_lift{z-index:1}.fb_iframe_widget_fluid{display:inline}.fb_iframe_widget_fluid span{width:100%}
.fb_mpn_mobile_landing_page_slide_out{animation-duration:200ms;animation-name:fb_mpn_landing_page_slide_out;transition-timing-function:ease-in}.fb_mpn_mobile_landing_page_slide_out_from_left{animation-duration:200ms;animation-name:fb_mpn_landing_page_slide_out_from_left;transition-timing-function:ease-in}.fb_mpn_mobile_landing_page_slide_up{animation-duration:500ms;animation-name:fb_mpn_landing_page_slide_up;transition-timing-function:ease-in}.fb_mpn_mobile_bounce_in{animation-duration:300ms;animation-name:fb_mpn_bounce_in;transition-timing-function:ease-in}.fb_mpn_mobile_bounce_out{animation-duration:300ms;animation-name:fb_mpn_bounce_out;transition-timing-function:ease-in}.fb_mpn_mobile_bounce_out_v2{animation-duration:300ms;animation-name:fb_mpn_fade_out;transition-timing-function:ease-in}.fb_customer_chat_bounce_in_v2{animation-duration:300ms;animation-name:fb_bounce_in_v2;transition-timing-function:ease-in}.fb_customer_chat_bounce_in_from_left{animation-duration:300ms;animation-name:fb_bounce_in_from_left;transition-timing-function:ease-in}.fb_customer_chat_bounce_out_v2{animation-duration:300ms;animation-name:fb_bounce_out_v2;transition-timing-function:ease-in}.fb_customer_chat_bounce_out_from_left{animation-duration:300ms;animation-name:fb_bounce_out_from_left;transition-timing-function:ease-in}.fb_invisible_flow{display:inherit;height:0;overflow-x:hidden;width:0}@keyframes fb_mpn_landing_page_slide_out{0%{margin:0 12px;width:100% - 24px}60%{border-radius:18px}100%{border-radius:50%;margin:0 24px;width:60px}}@keyframes fb_mpn_landing_page_slide_out_from_left{0%{left:12px;width:100% - 24px}60%{border-radius:18px}100%{border-radius:50%;left:12px;width:60px}}@keyframes fb_mpn_landing_page_slide_up{0%{bottom:0;opacity:0}100%{bottom:24px;opacity:1}}@keyframes fb_mpn_bounce_in{0%{opacity:.5;top:100%}100%{opacity:1;top:0}}@keyframes fb_mpn_fade_out{0%{bottom:30px;opacity:1}100%{bottom:0;opacity:0}}@keyframes fb_mpn_bounce_out{0%{opacity:1;top:0}100%{opacity:.5;top:100%}}@keyframes fb_bounce_in_v2{0%{opacity:0;transform:scale(0, 0);transform-origin:bottom right}50%{transform:scale(1.03, 1.03);transform-origin:bottom right}100%{opacity:1;transform:scale(1, 1);transform-origin:bottom right}}@keyframes fb_bounce_in_from_left{0%{opacity:0;transform:scale(0, 0);transform-origin:bottom left}50%{transform:scale(1.03, 1.03);transform-origin:bottom left}100%{opacity:1;transform:scale(1, 1);transform-origin:bottom left}}@keyframes fb_bounce_out_v2{0%{opacity:1;transform:scale(1, 1);transform-origin:bottom right}100%{opacity:0;transform:scale(0, 0);transform-origin:bottom right}}@keyframes fb_bounce_out_from_left{0%{opacity:1;transform:scale(1, 1);transform-origin:bottom left}100%{opacity:0;transform:scale(0, 0);transform-origin:bottom left}}@keyframes slideInFromBottom{0%{opacity:.1;transform:translateY(100%)}100%{opacity:1;transform:translateY(0)}}@keyframes slideInFromBottomDelay{0%{opacity:0;transform:translateY(100%)}97%{opacity:0;transform:translateY(100%)}100%{opacity:1;transform:translateY(0)}}
  </style>
 </head>
 <body>
  <input id="fbAppId" style="display: none" value="679802069155934"/>
  <script defer="defer" src="/js/app-vendors.920c5fe1.js">
  </script>
  <script defer="defer" src="/js/app.0148dd52.js">
  </script>
  <link href="../../../css/app.8237dba9.css" rel="stylesheet"/>
  <link href="../../../img/icons/favicon.svg" rel="icon" type="image/svg+xml"/>
  <link href="../../../img/icons/favicon-32x32.png" rel="icon" sizes="32x32" type="image/png"/>
  <link href="../../../img/icons/favicon-16x16.png" rel="icon" sizes="16x16" type="image/png"/>
  <link href="../../../manifest.json" rel="manifest"/>
  <meta content="#FFD000" name="theme-color"/>
  <meta content="no" name="apple-mobile-web-app-capable"/>
  <meta content="default" name="apple-mobile-web-app-status-bar-style"/>
  <meta content="Shortform" name="apple-mobile-web-app-title"/>
  <link href="../../../img/icons/apple-touch-icon-152x152.png" rel="apple-touch-icon"/>
  <link color="#FFD000" href="../../../img/icons/safari-pinned-tab.svg" rel="mask-icon"/>
  <meta content="/img/icons/msapplication-icon-144x144.png" name="msapplication-TileImage"/>
  <meta content="#000000" name="msapplication-TileColor"/>
  <script>
   window.fbAsyncInit = function () {
      var appId = document.getElementById('fbAppId').value
      FB.init({
        appId: appId,
        autoLogAppEvents: true,
        xfbml: true,
        version: 'v4.0',
      })
    }
  </script>
  <script async="" defer="defer" src="https://connect.facebook.net/en_US/sdk.js">
  </script>
  <noscript>
   <iframe height="0" src="https://www.googletagmanager.com/ns.html?id=GTM-TZKKGXF" style="display: none; visibility: hidden" width="0">
   </iframe>
  </noscript>
  <div data-v-app="" id="appRoot">
   <div class="sf-app" id="app" style="--vh: 6px;">
    <div id="iosFix">
    </div>
    <div>
     <!-- -->
     <div class="layout">
      <div class="wrapper">
       <section class="title-section">
        <div class="container">
         <h1 class="title-section__title">
          An American Sickness
         </h1>
        </div>
       </section>
       <section class="book-reading background-section">
        <div class="container book-reading__content control-container">
         <div class="back">
          <div class="preview-container">
           <a class="back__btn" href="../../../app">
            <span class="back__icon iconfont iback">
            </span>
            Back to Discover
           </a>
          </div>
         </div>
         <div class="control--active control">
          <div class="control__box">
           <div class="control__btn font-btn" title="Reading settings">
            <div class="control__icon-box">
             <span class="control__icon iconfont icontrol-font">
             </span>
            </div>
            <!-- -->
           </div>
           <div class="control__btn menu-btn" title="Table of contents">
            <div class="control__icon-box">
             <span class="control__icon iconfont icontrol-menu">
             </span>
            </div>
            <div class="control-menu" style="display: none;">
             <div class="control-menu__content" style="display: none;">
              <a class="control-menu__close">
               <span class="control-menu__close-icon iconfont isummary-close">
               </span>
              </a>
              <div class="return-box__toc">
               <a class="return-box__link" href="../../../app/book/an-american-sickness/preview">
                <span class="return-box__icon iconfont iprev">
                </span>
                Back to preview page
               </a>
              </div>
              <ul class="control-menu__list">
               <li class="control-menu__unit control-menu__one-page">
                <a class="router-link-active control-menu__link" href="../../../app/book/an-american-sickness">
                 <span class="isummary-1-page control-menu__icon iconfont">
                 </span>
                 <span>
                  1-Page Summary
                 </span>
                </a>
               </li>
               <li class="control-menu__unit control-menu__full-summary control-menu__unit--has-child">
                <a class="control-menu__link" role="button">
                 <span class="isummary-chapter active control-menu__icon iconfont">
                 </span>
                 <div>
                  <span>
                   Full Book Guide
                  </span>
                  <span class="control-menu__menu-icon iconfont isub-menu">
                  </span>
                 </div>
                </a>
                <ul class="control-menu__sub" style="display: none;">
                 <li class="control-menu__sub-unit">
                  <a class="control-menu__sub-link" href="../../../app/book/an-american-sickness/introduction">
                   <span class="control-menu__icon iconfont isummary-chapter">
                   </span>
                   <span>
                    Introduction
                   </span>
                  </a>
                 </li>
                 <li class="control-menu__sub-unit">
                  <a class="control-menu__sub-link" href="../../../app/book/an-american-sickness/part-i">
                   <span class="control-menu__icon iconfont isummary-chapter">
                   </span>
                   <span>
                    Part I: History | Chapter 1: Problems with Insurance
                   </span>
                  </a>
                 </li>
                 <li class="control-menu__sub-unit">
                  <a class="control-menu__sub-link" href="../../../app/book/an-american-sickness/chapter-2">
                   <span class="control-menu__icon iconfont isummary-chapter">
                   </span>
                   <span>
                    Chapter 2: Problems with Hospitals
                   </span>
                  </a>
                 </li>
                 <li class="control-menu__sub-unit">
                  <a class="control-menu__sub-link" href="../../../app/book/an-american-sickness/chapter-3">
                   <span class="control-menu__icon iconfont isummary-chapter">
                   </span>
                   <span>
                    Chapter 3: Problems with Physicians
                   </span>
                  </a>
                 </li>
                 <li class="control-menu__sub-unit control-menu__sub-unit--active">
                  <a aria-current="page" class="router-link-active router-link-exact-active control-menu__sub-link" href="../../../app/book/an-american-sickness/chapter-4">
                   <span class="control-menu__icon iconfont isummary-chapter active">
                   </span>
                   <span>
                    Chapter 4: Problems with Pharmaceuticals
                   </span>
                  </a>
                 </li>
                 <li class="control-menu__sub-unit">
                  <a class="control-menu__sub-link" href="../../../app/book/an-american-sickness/chapter-5">
                   <span class="control-menu__icon iconfont isummary-chapter">
                   </span>
                   <span>
                    Chapter 5: Problems with Medical Devices
                   </span>
                  </a>
                 </li>
                 <li class="control-menu__sub-unit">
                  <a class="control-menu__sub-link" href="../../../app/book/an-american-sickness/chapter-6">
                   <span class="control-menu__icon iconfont isummary-chapter">
                   </span>
                   <span>
                    Chapter 6: Problems with Testing and Ancillary Services
                   </span>
                  </a>
                 </li>
                 <li class="control-menu__sub-unit">
                  <a class="control-menu__sub-link" href="../../../app/book/an-american-sickness/chapter-7">
                   <span class="control-menu__icon iconfont isummary-chapter">
                   </span>
                   <span>
                    Chapter 7: Problems with Contractors
                   </span>
                  </a>
                 </li>
                 <li class="control-menu__sub-unit">
                  <a class="control-menu__sub-link" href="../../../app/book/an-american-sickness/chapter-8">
                   <span class="control-menu__icon iconfont isummary-chapter">
                   </span>
                   <span>
                    Chapter 8: Problems with Research and Non-Profits
                   </span>
                  </a>
                 </li>
                 <li class="control-menu__sub-unit">
                  <a class="control-menu__sub-link" href="../../../app/book/an-american-sickness/chapter-9">
                   <span class="control-menu__icon iconfont isummary-chapter">
                   </span>
                   <span>
                    Chapter 9: Problems with Conglomerates
                   </span>
                  </a>
                 </li>
                 <li class="control-menu__sub-unit">
                  <a class="control-menu__sub-link" href="../../../app/book/an-american-sickness/chapter-11">
                   <span class="control-menu__icon iconfont isummary-chapter">
                   </span>
                   <span>
                    Chapter 11: Problems with the Affordable Care Act
                   </span>
                  </a>
                 </li>
                 <li class="control-menu__sub-unit">
                  <a class="control-menu__sub-link" href="../../../app/book/an-american-sickness/exercise-reflect-on-your-healthcare">
                   <span class="control-menu__icon iconfont isummary-exercise">
                   </span>
                   <span>
                    Exercise: Reflect On Your Healthcare
                   </span>
                  </a>
                 </li>
                 <li class="control-menu__sub-unit">
                  <a class="control-menu__sub-link" href="../../../app/book/an-american-sickness/part-ii">
                   <span class="control-menu__icon iconfont isummary-chapter">
                   </span>
                   <span>
                    Part II: Treatment | Chapter 12: Healthcare Systems
                   </span>
                  </a>
                 </li>
                 <li class="control-menu__sub-unit">
                  <a class="control-menu__sub-link" href="../../../app/book/an-american-sickness/chapter-13">
                   <span class="control-menu__icon iconfont isummary-chapter">
                   </span>
                   <span>
                    Chapter 13: What to Do About Doctors’ Bills
                   </span>
                  </a>
                 </li>
                 <li class="control-menu__sub-unit">
                  <a class="control-menu__sub-link" href="../../../app/book/an-american-sickness/chapter-14">
                   <span class="control-menu__icon iconfont isummary-chapter">
                   </span>
                   <span>
                    Chapter 14: What to Do About Hospital Bills
                   </span>
                  </a>
                 </li>
                 <li class="control-menu__sub-unit">
                  <a class="control-menu__sub-link" href="../../../app/book/an-american-sickness/chapter-15">
                   <span class="control-menu__icon iconfont isummary-chapter">
                   </span>
                   <span>
                    Chapter 15: What to Do About Insurance Costs
                   </span>
                  </a>
                 </li>
                 <li class="control-menu__sub-unit">
                  <a class="control-menu__sub-link" href="../../../app/book/an-american-sickness/chapter-16">
                   <span class="control-menu__icon iconfont isummary-chapter">
                   </span>
                   <span>
                    Chapter 16: What to Do About Drug and Device Costs
                   </span>
                  </a>
                 </li>
                </ul>
               </li>
               <li class="control-menu__unit">
                <a class="control-menu__link" href="../../../app/book/an-american-sickness/highlights">
                 <span class="control-menu__icon iconfont isummary-highlights">
                 </span>
                 <span>
                  Highlights and Notes
                 </span>
                </a>
               </li>
               <li class="control-menu__unit">
                <a class="control-menu__link" href="../../../app/book/an-american-sickness/community">
                 <span class="control-menu__icon iconfont isummary-community">
                 </span>
                 <span>
                  Discussion
                 </span>
                </a>
               </li>
               <!-- -->
               <!-- -->
              </ul>
             </div>
            </div>
           </div>
           <!-- -->
           <div class="control__btn player-btn" title="Listen">
            <div class="control__icon-box">
             <span class="control__icon iconfont icontrol-listen">
             </span>
            </div>
           </div>
           <button class="control__btn favorite-btn" title="Add to favorites">
            <div class="control__icon-box">
             <span class="control__icon iconfont icontrol-favorite">
             </span>
             <span class="control__icon control__icon--active control__icon--favorite iconfont ifavorite">
             </span>
            </div>
           </button>
           <div class="control__btn night-btn" title="Night mode">
            <div class="control__icon-box">
             <span class="control__icon iconfont icontrol-night">
             </span>
            </div>
           </div>
          </div>
         </div>
         <div class="book-reading__content-editor content-editor font-medium line-medium margin-medium" style="font-family: Rotunda, sans-serif;">
          <div class="highlights-content prevent-content-drag chapter-text">
           <div class="sf-chapter" oncopy="return false">
            <h2>
             Chapter 4: Problems with Pharmaceuticals
            </h2>
            <h3 id="history-of-pharma">
             History of Pharma
            </h3>
            <p>
             Here’s an abbreviated history of pharmaceutical companies in the US:
            </p>
            <ul>
             <li>
              1906: The Wiley Act gave the US Bureau of Chemistry regulation power over drug safety. Since few medicines did anything of note, the focus was on preventing harm.
             </li>
             <li>
              1937: Sulfanilamide (an antibiotic for strep throat) was mixed with diethylene glycol and killed 100+ people. This prompted...
             </li>
             <li>
              1938: The Food Drug and Cosmetic Act required testing before drugs could be marketed, and it prohibited false therapeutic claims.
             </li>
             <li>
              1960: The anti-nausea medication thalidomide was given to pregnant women, but it caused birth defects in over 10,000 children in Europe with only 50% surviving. This tragedy led to...
             </li>
             <li>
              1962: The FDA now enforced methods for clinical testing and required medicines to be proven “safe and effective” beyond placebo.
              <ul>
               <li>
                Importantly,
                <strong>
                 concerns about relative value were not addressed
                </strong>
                here—there was no need to be “safe and effective beyond existing drugs” or to be cost-effective.
               </li>
              </ul>
             </li>
             <li>
              1984: Drug companies complain that the drug approval process takes time away from the 20-year patent protection period. Drug prices are also rising. In response, the Hatch-Waxman Act was passed:
              <ul>
               <li>
                Generic drugs got an easier path to approval. They didn’t need to fresh clinical trials, but rather just show chemical equivalence, and equivalence of bioavailability. This created the ANDA, or abbreviated new drug application.
               </li>
               <li>
                Manufacturers were given ways to extend patents, including:
                <ul>
                 <li>
                  A 3-year extension to support a change in dose form
                 </li>
                 <li>
                  7-year exclusivity for orphan drugs (those treating rare conditions)
                 </li>
                 <li>
                  6-month extension for pediatric trials
                 </li>
                 <li>
                  5-year extension for claims of “time lost in regulatory review,” during which generic markers couldn’t submit applications
                 </li>
                </ul>
               </li>
              </ul>
             </li>
             <li>
              1980s: HIV concern led to rapid approval of AZT (1 human trial that lasted 19 weeks was sufficient for approval) and other antivirals. At the time, these became the most expensive drugs in history.
              <ul>
               <li>
                What was
                <a href="https://www.nytimes.com/1989/08/28/opinion/azt-s-inhuman-cost.html" target="_blank">
                 likely driving up the price
                </a>
                : high public demand, high insurer willingness to pay, lack of substitutes, and perceived low market size by the manufacturer.
               </li>
               <li>
                This created a new paradigm for acceptable limits of drug pricing.
               </li>
              </ul>
             </li>
            </ul>
            <p>
             An important point:
             <strong>
              in the US, Medicare is legally prohibited from negotiating prices with pharmaceutical companies.
             </strong>
             In contrast, single-payer systems like that in the UK have more leverage to choose a subset of drugs to support and squeeze prices down.
            </p>
            <h3 id="clinical-trial-strategies">
             Clinical Trial Strategies
            </h3>
            <p>
             Pharma companies use a few strategies to speed up clinical trials to get drugs approved.
            </p>
            <h4 id="surrogate-measures">
             Surrogate Measures
            </h4>
            <p>
             The HIV rush for drugs prompted the FDA to allow
             <strong>
              surrogate measures
             </strong>
             , or proxies for health (like blood markers) instead of actually proving that the drug cured symptoms over months or years.
            </p>
            <p>
             Manufacturers promise to carry out follow-up studies, but there is no punishment for not doing so. Nor is there a mechanism to take drugs off the market if they later turn out to be inefficacious.
            </p>
            <h4 id="orphan-drugs">
             Orphan Drugs
            </h4>
            <p>
             Orphan drugs treat conditions affecting fewer than 200k patients. To incentivize pharma companies to develop treatments, orphan drugs get a few perks:
            </p>
            <ul>
             <li>
              Smaller clinical trials and shorter trials are allowed
             </li>
             <li>
              An approved drug bars the FDA for approving any other application for the same drug for the same disease for 7 years, even if the drug’s patent has expired. This limits generic competition.
             </li>
            </ul>
            <p>
             For example, the melatonin analogue tasimelteon (Vanda) targeted Non-24, an orphan disease. It was approved despite not showing clinical advantages over melatonin.
            </p>
            <h4 id="the-fdas-incentives">
             The FDA’s Incentives
            </h4>
            <p>
             The FDA gets
             <a href="https://www.fda.gov/ForIndustry/UserFees/PrescriptionDrugUserFee/" target="_blank">
              $2.5 million per drug application
             </a>
             . Thus, the agency has incentives to receive more applications for me-too drugs, even if they improve little beyond what already exists.
            </p>
            <h3 id="drug-advertising">
             Drug Advertising
            </h3>
            <p>
             The Supreme Court has protected drug advertising under free speech.
             <strong>
              The United States is only one of two countries allowing drug advertising
             </strong>
             , along with New Zealand. Other areas like the EU don’t allow commercial speech the same equivalence in free speech, considering drug advertising harmful to the public since it overpromises the benefits of wonder drugs.
            </p>
            <p>
             Drug advertising began in the 1990s, with “help-seeking ads” where either the drug or disease could be mentioned, but not both. In 1997, ads could contain both the condition and the medicine, but they also had to include all side effects and contraindications
            </p>
            <h3 id="generics">
             Generics
            </h3>
            <p>
             After a drug patent expires, other companies can submit a generic drug for approval. Typically, these far lower the cost of the drug.
            </p>
            <p>
             However, the process is convoluted.
            </p>
            <ul>
             <li>
              Before the patent expires, the generic manufacturer can seek approval.
             </li>
             <li>
              The first company to submit an ANDA has an exclusive right to marketing among ANDAs for 180 days.
              <ul>
               <li>
                This does not block “authorized generics,” which are produced by the patent holder, are the same drug on a private label, and compete with the ANDA.
               </li>
              </ul>
             </li>
             <li>
              However, filing an ANDA before the patent expires is considered “constructive infringement” of the patent. If the patent holder files an infringement suit, the FDA postpones the generic drug for 30 months, unless before that time the patent expires or is judged invalid/not infringed.
             </li>
             <li>
              The generic maker can then countersue. The parties may reach a settlement, and sometimes the generic maker accepts a payment to delay their introduction of their generic, which gives the patent holder more time to enjoy higher prices.
             </li>
            </ul>
            <p>
             Generics aren’t a panacea for drug prices either. The economics for generics don’t always work out, causing competitors to pull out and leaving a single manufacturer with a virtual monopoly for a period of time. It’s said that
             <a href="https://www.nytimes.com/2017/04/14/business/lannett-drug-price-hike-bedrosian.html?mtrref=www.google.com" target="_blank">
              3 or fewer generic manufacturers are insufficient to provide price competition
             </a>
             .
            </p>
            <h3 id="strategies-to-extend-patents-and-fight-generics">
             Strategies to Extend Patents and Fight Generics
            </h3>
            <p>
             When patents end, pharma companies don’t just call it quits. There are a variety of ways to enjoy continued exclusivity and to fight generics.
            </p>
            <h4 id="product-hopping">
             Product Hopping
            </h4>
            <p>
             By law, generics must be identical in dosage and form to the brand-name drug for a pharmacist to substitute them. States have different laws on the ability of pharmacists to substitute generics for brand-name drugs—some mandate substitution when possible, while others require patient consent.
            </p>
            <p>
             To stymie the effort of pharmacies to substitute drugs, pharma companies will create new forms of the product to make it harder to substitute a generic with identical dosage and form. This is called “product hopping.” Here’s how it works.
            </p>
            <p>
             Before their patent expires,
             <strong>
              the pharma company changes the form, dosing, and route of administration
             </strong>
             . For example, they might change from a pill that’s swallowed to a chewable pill. These changes require a new application to the FDA.
            </p>
            <p>
             Then the pharma company destroys all previous forms of the drug, or they raise prices on the previous forms, to push prescriptions to switch to the new form, before generics arrive on the market. Finally,
             <strong>
              once the generic arrives, it can’t be directly substituted by the pharmacist
             </strong>
             .
            </p>
            <p>
             This isn’t a total blocker. The doctor could theoretically prescribe the generic, even if it’s for the older dosage and form. But doctor habit, as well as low marketing from the generics, prevent this from fully happening.
            </p>
            <p>
             This is said to illustrate market failure, since the brand name having a minor time lead leads to large long term sales differences. (Shortform note: some of the details came not from the book but from this useful
             <a href="https://www.ftc.gov/sites/default/files/documents/amicus_briefs/mylan-pharmaceuticals-inc.et-al.v.warner-chilcott-public-limited-company-et-al./121127doryxamicusbrief.pdf" target="_blank">
              FTC amicus brief
             </a>
             .)
            </p>
            <h4 id="take-it-over-the-counter">
             Take it Over the Counter
            </h4>
            <p>
             By law, the same product cannot be on the market as both a prescription and over-the-counter (OTC) product. Further, any company that takes a prescription drug to OTC gets 3 years of market exclusivity (since it requires submitting a new application with safety data).
            </p>
            <p>
             Once a drug goes OTC, generics manufacturers have 6 months to use up their supply.
            </p>
            <p>
             The patent holder can then also patent a new formulation or molecule similar to the now OTC drug, and enjoy both OTC and prescription sales. For the drug Flonase, Glaxo employed both strategies.
            </p>
            <p>
             Typically, drugs that go OTC need a large market size to make up for cheaper prices.
            </p>
            <h4 id="other-tactics">
             Other Tactics
            </h4>
            <p>
             As we’ve discussed, pharma companies sue generic makers, or partner with them to delay the introduction of generics. Here are other tactics that can lead to protection of patented status.
            </p>
            <p>
             Pharma companies can patent a new drug combination of two off-patent drugs. For example, Duexis is the combination of the two generic drugs, ibuprofen and famotidine.
            </p>
            <p>
             Pharma companies deliberately use different formulations that are more difficult to prove bioequivalence. For example, sprays, lotions, creams are more difficult to replicate than pills
            </p>
            <p>
             Pharma companies strike long contracts with hospitals to take their branded drugs. This reduces the market size for new generics.
            </p>
            <p>
             Pharma companies may even help promote information that suggests the generic substitute is dangerous. In the early 2000s, the anti-nausea drug Zofran faced competition with generic droperidol. Suddenly, the FDA issued a warning that droperidol may cause heart arrhythmias. The generics disappeared from the market, and suddenly only Zofran remained.
            </p>
            <h3 id="co-pay-assistance">
             Co-Pay Assistance
            </h3>
            <p>
             What if patients can’t afford their co-pays on the drugs? Pharma companies have a scheme for that too.
            </p>
            <p>
             <strong>
              The pharma company sets up a nonprofit that helps patients pay co-pays.
             </strong>
             This is net better for the pharma company anyway—the insurer is paying most of the drug’s cost.
            </p>
            <p>
             For example, say a drug costs $5000, and the patient’s co-pay is $1250. Pharma covers the co-pay, and it gets $3750 for a sale that wouldn’t otherwise have happened. The drug price remains high, insurance reimburses, and pharma gets marginal sales.
            </p>
            <p>
             <strong>
              This strategy neutralizes the advantage of cheaper drugs for the consumer
             </strong>
             —without pricing pressure, consumers pick the drug they like most, or the most expensive one.
            </p>
            <p>
             The patient’s copay might even be higher with a cheaper competitor that doesn’t have this co-pay assistance program. For the example above, say a competitor has a $1000 drug that costs the patient $200 in co-pay. The patient would obviously rather choose the $0 copay drug, even if it costs the medical system far more.
            </p>
            <p>
             Medicare forbids co-pay offers directly from pharma firm foundations. However, private insurers aren’t barred from this, and they face competitive pressure to allow it—if one insurer didn’t allow it, patients would quickly leave for a competing insurer. Unfortunately, this sets up a crisis when the patient goes on Medicare and can no longer afford drugs.
            </p>
            <p>
             Best of all—this co-pay assistance is tax-deductible for pharma companies.
            </p>
            <h3 id="pharmacy-benefit-managers-pbms">
             Pharmacy Benefit Managers (PBMs)
            </h3>
            <p>
             Pharmacy benefit managers are hired by insurers and employers to negotiate drug purchases with pharmacies. Per antitrust law, insurers cannot compare prices they pay for medicine, but PBMs can.
            </p>
            <p>
             The largest PBMs are Express Scripts, CVS Caremark, and OptumRx.
            </p>
            <p>
             PBMs pocket a percentage of discounts they negotiate. Thus they put drugs that net them the best deals, not necessarily the drugs that are most in demand.
            </p>
            <p>
             Furthermore, they may treat individual drugs as strategic pieces in a chess game. They can drop certain drugs from coverage to pressure pharma companies for better deals, with patients as collateral damage as they scramble to find alternatives.
            </p>
            <h3 id="medicare-part-d">
             Medicare Part D
            </h3>
            <p>
             Medicare Part D was started in 2006 as a way to make drugs more affordable for patients. Before this, Medicare seniors had to pay out of pocket.
            </p>
            <p>
             Part D had a unique co-pay structure:
            </p>
            <ul>
             <li>
              The first $320 was a deductible, fully paid by the patient.
             </li>
             <li>
              The next $2,960 required a 25% copay.
             </li>
             <li>
              The next $1,740 required a 100% copay. This was known as the “donut hole” and was intended to make patients think twice about taking expensive medication.
             </li>
             <li>
              After this, the copay reduces to 5%.
             </li>
            </ul>
            <p>
             The unintended effect of Part D was that
             <strong>
              seniors now had guaranteed drug coverage and ample budgets to spend on medicines
             </strong>
             . Pharma companies quickly pushed up prices for essential medicines, sometimes to multiples what they used to cost.
            </p>
            <p>
             As economics would predict, every incentive and opportunity is exploited by market participants.
            </p>
            <h3 id="the-factor-viii-story">
             The Factor VIII story
            </h3>
            <p>
             Factor VIII is a treatment for the bleeding disorder hemophilia. Here’s a story about how this old treatment has become progressively more expensive over time.
            </p>
            <ul>
             <li>
              In the 1960s, Factor VIII was made available and priced at $3,000. This price was shocking at the time. This was made from donated blood.
             </li>
             <li>
              In the 1980s, HIV and hepatitis C infected the blood supply, requiring new blood treatment processes to kill viruses in blood. This nearly tripled prices, rising to 40 cents per unit.
             </li>
             <li>
              In the 1990s, the gene for Factor VIII was isolated, allowing for Factor VIII to be generated in the lab without needing human blood. Despite being cheaper to produce, these were priced
              <em>
               even higher
              </em>
              than the older blood-derived Factor VIII at $1/unit. In response, manufacturers of blood-derived Factor VIII didn’t compete by lowering prices—emboldened by the higher prices, they
              <em>
               raised
              </em>
              prices to 60 cents/unit.
             </li>
             <li>
              Now that Factor VIII was no longer in short supply, patients could take it three times a week rather than saving it for an emergency. The total cost of treatment now exceeds $300,000 to $600,000 per year.
             </li>
             <li>
              An industry of home-delivered factor VIII began. Patients started effectively getting kickbacks from manufacturers for switching to them. Even though kickbacks are illegal, manufacturers arranged a workaround—they would sell home care company units of Factor VIII, then home care companies would sign patients with free perks and rewards.
             </li>
             <li>
              Finally, if the patient can’t afford Factor VIII, the manufacturer has a co-pay assistance plan, so the patient doesn’t pay out of pocket. Instead, the expenses are pushed to the insurer, and ultimately to the employer.
             </li>
            </ul>
           </div>
           <!-- -->
          </div>
          <!-- -->
         </div>
         <div class="book-reading-nav">
          <div class="book-reading-nav__container">
           <a class="book-reading-nav__prev-box" href="../../../app/book/an-american-sickness/chapter-3.html">
            <div class="book-reading-nav__link">
             <span class="book-reading-nav__icon iconfont iprev">
             </span>
             Previous
            </div>
            <p class="book-reading-nav__name book-reading-nav__prev-name">
             Chapter 3: Problems with Physicians
            </p>
           </a>
          </div>
          <div class="book-reading-nav__container">
           <a class="book-reading-nav__next-box" href="../../../app/book/an-american-sickness/chapter-5.html">
            <div class="book-reading-nav__link book-reading-nav__next">
             Next
             <span class="book-reading-nav__icon iconfont inext">
             </span>
            </div>
            <p class="book-reading-nav__name book-reading-nav__next-name">
             Chapter 5: Problems with Medical Devices
            </p>
           </a>
          </div>
         </div>
        </div>
        <!-- -->
       </section>
      </div>
     </div>
     <!-- -->
    </div>
   </div>
  </div>
  <iframe allow="payment *" allowtransparency="true" aria-hidden="true" frameborder="0" name="__privateStripeMetricsController2830" role="presentation" scrolling="no" src="https://js.stripe.com/v3/m-outer-27c67c0d52761104439bb051c7856ab1.html#url=https%3A%2F%2Fwww.shortform.com%2Fapp%2Fbook%2Fan-american-sickness%2Fchapter-4&amp;title=&amp;referrer=&amp;muid=21e24f53-a857-4d61-bc72-964f9ecc7dc1ef0052&amp;sid=1ca3f592-0112-439f-b0f1-7ebb71c7f6f6448177&amp;version=6&amp;preview=false" style="border: none !important; margin: 0px !important; padding: 0px !important; width: 1px !important; min-width: 100% !important; overflow: hidden !important; display: block !important; visibility: hidden !important; position: fixed !important; height: 1px !important; pointer-events: none !important; user-select: none !important;" tabindex="-1">
  </iframe>
  <script id="" type="text/javascript">
   !function(b,e,f,g,a,c,d){b.fbq||(a=b.fbq=function(){a.callMethod?a.callMethod.apply(a,arguments):a.queue.push(arguments)},b._fbq||(b._fbq=a),a.push=a,a.loaded=!0,a.version="2.0",a.queue=[],c=e.createElement(f),c.async=!0,c.src=g,d=e.getElementsByTagName(f)[0],d.parentNode.insertBefore(c,d))}(window,document,"script","https://connect.facebook.net/en_US/fbevents.js");
try{var data=localStorage.getItem("user");if(data){var user=JSON.parse(data);fbq("init","1757032084430692",{external_id:user.id})}else fbq("init","1757032084430692")}catch(b){fbq("init","1757032084430692"),console.log("FB pixel setup error",b)}fbq("track","PageView",{value:0,currency:"USD"});
  </script>
  <noscript>
   <img height="1" src="https://www.facebook.com/tr?id=1757032084430692&amp;ev=PageView&amp;noscript=1" style="display:none" width="1"/>
  </noscript>
  <script id="" type="text/javascript">
   (function(c,d,f,g,e){c[e]=c[e]||[];var h=function(){var b={ti:"56018282"};b.q=c[e];c[e]=new UET(b);c[e].push("pageLoad")};var a=d.createElement(f);a.src=g;a.async=1;a.onload=a.onreadystatechange=function(){var b=this.readyState;b&&"loaded"!==b&&"complete"!==b||(h(),a.onload=a.onreadystatechange=null)};d=d.getElementsByTagName(f)[0];d.parentNode.insertBefore(a,d)})(window,document,"script","//bat.bing.com/bat.js","uetq");
  </script>
  <div style="display: none; visibility: hidden;">
   <script async="null" data-account="105016" data-user="93737" src="https://a.omappapi.com/app/js/api.min.js" type="text/javascript">
   </script>
  </div>
  <div style="display: none; visibility: hidden;">
   <script data-pw-auth="c6dc03294186bb2dc0dac6ce90817285" id="profitwell-js">
    (function(b,d,a,f,g,c,e){b[a]=b[a]||function(){(b[a].q=b[a].q||[]).push(arguments)};c=d.createElement(f);e=d.getElementsByTagName(f)[0];c.async=1;c.src=g+"?auth\x3d"+d.getElementById(a+"-js").getAttribute("data-pw-auth");e.parentNode.insertBefore(c,e)})(window,document,"profitwell","script","https://public.profitwell.com/js/profitwell.js");var user=localStorage.user;if(user){var email=JSON.parse(user).email;profitwell("start",{user_email:email})}else profitwell("start",{});
   </script>
  </div>
  <div class="annotator-adder annotator-hide">
   <button class="add-highlight" type="button">
    <i class="iconfont ihighlights">
    </i>
   </button>
   <button class="add-note iconfont inotes" type="button">
   </button>
   <button class="share-note iconfont ifacebook-1" type="button">
   </button>
   <button class="share-note iconfont itwitter-1" type="button">
   </button>
   <button class="share-note iconfont ishare-1" type="button">
   </button>
  </div>
  <div class="annotator-adder annotator-hide annotator-remover">
   <button class="add-highlight" type="button">
    <i class="iconfont ihighlights">
    </i>
   </button>
   <button class="add-note iconfont inotes" type="button">
   </button>
   <button class="share-note iconfont ifacebook-1" type="button">
   </button>
   <button class="share-note iconfont itwitter-1" type="button">
   </button>
   <button class="share-note iconfont ishare-1" type="button">
   </button>
  </div>
  <div class="annotator-outer annotator-viewer annotator-hide">
   <ul class="annotator-widget annotator-listing">
   </ul>
  </div>
  <div id="batBeacon539087251056" style="width:0px; height:0px; display:none; visibility:hidden;">
   <img alt="" height="0" id="batBeacon825672157193" src="https://bat.bing.com/action/0?ti=56018282&amp;Ver=2&amp;mid=bacaceef-8b80-43bb-a60b-a66f1804c9f0&amp;sid=201ffde0635411ee902411d77b750559&amp;vid=20202bf0635411ee9ac03f2e618b0b9f&amp;vids=0&amp;msclkid=N&amp;pi=0&amp;lg=en-US&amp;sw=800&amp;sh=600&amp;sc=24&amp;nwd=1&amp;tl=Shortform%20%7C%20An%20American%20Sickness&amp;p=https%3A%2F%2Fwww.shortform.com%2Fapp%2Fbook%2Fan-american-sickness%2Fchapter-4&amp;r=&amp;lt=297&amp;evt=pageLoad&amp;sv=1&amp;rn=162951" style="width:0px; height:0px; display:none; visibility:hidden;" width="0"/>
  </div>
  <div id="om-nrd32ircuzkjfucqqtl4-holder">
  </div>
  <div id="om-tuzeqn73no5jvndln30n-holder">
  </div>
  <div id="om-dvbrmog97vuvleydmpei-holder">
  </div>
  <div id="om-agmwdbfgpfiknobuuyar-holder">
  </div>
  <div id="om-yjgz6qpkdh7zlbc4asus-holder">
  </div>
  <div id="om-o59nuac3o4jmrfxd1tdc-holder">
  </div>
  <div id="om-ufkpty5hak4unhts2reb-holder">
  </div>
  <div id="om-a7ojhiis3mu29i0sfthz-holder">
  </div>
  <div id="om-xrp8a4gkuybha6nrpodq-holder">
  </div>
  <div id="om-gifziuqc0j2pfpu4t00o-holder">
  </div>
  <div id="om-esprroyh2dilq5ijncpa-holder">
  </div>
  <div id="om-audjl6pe8nupf6guxysj-holder">
  </div>
  <div id="om-y3wn6zmsmpxa8otwrsiu-holder">
  </div>
  <div id="om-cgjqzqcocxu6uhxwbgrk-holder">
  </div>
  <div id="om-v4j87ywocsuaxvct1ql9-holder">
  </div>
  <div id="om-qlevta0rp7gtdjleoneh-holder">
  </div>
  <div id="om-mw3phum8lyvfvhbcofzl-holder">
  </div>
  <div id="om-cnv03j3kumnovay4yamq-holder">
  </div>
  <div id="om-ced4lwlbcmlqul9oq2h9-holder">
  </div>
  <div id="om-qzt6snbvkhs84ouumjlz-holder">
  </div>
  <div id="om-udyf7drdvidhlrqqqubp-holder">
  </div>
  <div id="om-mwlpozjxqn4ye9jojwrb-holder">
  </div>
  <div id="om-jusgddnutelfqr0qssvv-holder">
  </div>
  <div id="om-qgwi2mdnsalbclh078jh-holder">
  </div>
  <div id="om-ye9nxsgzcyche2e3u2wv-holder">
  </div>
  <div id="om-ezasgu9p5n8jcjvzxr6g-holder">
  </div>
  <div id="om-e5yi9e4p5awae68xdnjc-holder">
  </div>
  <div id="om-tqczpcffgkptqre36wge-holder">
  </div>
  <div id="om-vxnpysk5cniitja6gber-holder">
  </div>
  <div id="om-r3qfbjgbhkeyivnyxfpu-holder">
  </div>
  <div id="om-znn1ehwzn1ciitpvcdjr-holder">
  </div>
  <div id="om-ttqbfjuzolgrkupsghnc-holder">
  </div>
  <div id="om-reupr85odj4osbgmq8ap-holder">
  </div>
  <div id="om-th9qqyl4u4y9genwzln5-holder">
  </div>
  <div id="om-twwpdqktjzp8azmefpam-holder">
  </div>
  <div id="om-ldawpnitwcnj906b6iyb-holder">
  </div>
  <div id="om-tnqusqw03ziedvxxvdfc-holder">
  </div>
  <div id="om-v438u7ooitlmk8dbco2x-holder">
  </div>
  <div id="om-l6x44whluegwo4rywfx4-holder">
  </div>
  <div id="om-rycg5xc06wdti4hf9whk-holder">
  </div>
  <div id="om-uz5v7ahpf65yk6jk6lbk-holder">
  </div>
  <div id="om-jvgc1d5hxze0ej3jrtkp-holder">
  </div>
  <div id="om-b0iwvajuxon5verimzam-holder">
  </div>
  <div id="om-vkagziz4aczcvd03mdgr-holder">
  </div>
  <div id="om-ddg0jqc46q7m8zyhcb6q-holder">
  </div>
  <div id="om-gtopz55rrdycogg8kkmq-holder">
  </div>
  <div id="om-ihqfvtf0uuryk8loksrj-holder">
  </div>
  <div id="om-fyb7gqjt43xajx6jgazk-holder">
  </div>
  <div id="om-vcwwunkxdzsrpeshakon-holder">
  </div>
  <div id="om-hctmrxk7vyoo6qnzpieg-holder">
  </div>
  <div id="om-hbsieiwssdjrdirw3sis-holder">
  </div>
  <div id="om-tybhyruhpirzhn8pscmu-holder">
  </div>
  <div id="om-kedfs0yceopwcva8upki-holder">
  </div>
  <div id="om-maqhmxbxmthpk4tggflc-holder">
  </div>
  <div id="om-zqpx5hxikxjwmaia3pxs-holder">
  </div>
  <div id="om-eoal8g5eqr7a0ji6ofnc-holder">
  </div>
  <div id="om-r7711rmk13eyp6jf5ix9-holder">
  </div>
  <div id="om-nhcdidkqs5fqjhe0p3nh-holder">
  </div>
  <div id="om-kpyv9tpniydtzklkemfc-holder">
  </div>
  <div id="om-fvxclhem9c22vyicitci-holder">
  </div>
  <div id="om-ejgemkdu1c1nrnzjjrdy-holder">
  </div>
  <div id="om-q6axkajoiyzfmzmdfwvv-holder">
  </div>
  <div id="om-i6o9eykacj0vl3m8b1pj-holder">
  </div>
  <div id="om-wxxqi2edov9cg3m0tegh-holder">
  </div>
  <div id="om-z77tqwqui9g0s2iswqkh-holder">
  </div>
  <div id="om-jpsoxti7l1b9sdsw0a12-holder">
  </div>
  <div id="om-w2iqh65vckatvez9hc9w-holder">
  </div>
  <div id="om-bjslcorwvfthq6smtqqu-holder">
  </div>
  <div id="om-wg4pp12bonvxas9jyteg-holder">
  </div>
  <div id="om-s4zhnjzu5izgo7vl6niq-holder">
  </div>
  <div id="om-pvvijvfetg0iplagpg1l-holder">
  </div>
  <div id="om-dairxv58orvzz90vbqnw-holder">
  </div>
  <div id="om-nofon6dewg8q2hyvvtur-holder">
  </div>
  <div id="om-uiobbs802ux4axfyzkih-holder">
  </div>
  <div id="om-bucwdnejdmxywp07ovuh-holder">
  </div>
  <div id="om-vn7t1nburiiddinsyedo-holder">
  </div>
  <div id="om-uoyham6yrzcjiluxetne-holder">
  </div>
  <div id="om-vcmouls6o0mssecp65ye-holder">
  </div>
  <div id="om-l1ibgix7bcchikguv94p-holder">
  </div>
  <div id="om-jz1thlcx7s12zjq10vo5-holder">
  </div>
  <div id="om-ysf6w8mx9ybmgml6nym1-holder">
  </div>
  <div id="om-kb6nax5xebtniifl1qsb-holder">
  </div>
  <div id="om-op4eibpndfgcoyv072w3-holder">
  </div>
  <div id="om-ohmbx8q2ombjiejoyvib-holder">
  </div>
  <div id="om-tjyueurzcxo6lta4ajmg-holder">
  </div>
  <div id="om-ii92kmjwjre6ag29qxjl-holder">
  </div>
  <div id="om-nzu1yabu1gtsjiv0qd4r-holder">
  </div>
  <div id="om-vvmuvhvpk91gijeo0caf-holder">
  </div>
  <div id="om-xun0sddw314eqccocybi-holder">
  </div>
  <div id="om-ztiotgjnwyyy6lqyfduq-holder">
  </div>
  <div id="om-xgjtbzy2x3osmbloqjxm-holder">
  </div>
  <div id="om-vgnwfwagrllujiwwwfra-holder">
  </div>
  <div id="om-fmtfthg8oimkhlxuuzga-holder">
  </div>
  <div id="om-r3py7e6rr8qiuwxpsurt-holder">
  </div>
  <div id="om-mqq9xmhpwdpgktgt176h-holder">
  </div>
  <div id="om-hm17sktrxeeyk2arl4jp-holder">
  </div>
  <div id="om-qcaocuuxmliwarka5bnk-holder">
  </div>
  <div id="om-fyq65hphgk3103ehzfvm-holder">
  </div>
  <div id="om-ovxkrmmyrjympr4fq9ll-holder">
  </div>
  <div id="om-hu2yyhinmfcrlbxaodej-holder">
  </div>
  <div id="om-akkhbk77cqrhb4zovy3v-holder">
  </div>
  <div id="om-nk06ghj2ixsi6b1wowpp-holder">
  </div>
  <div id="om-ehkfbfd3xbkqlnacvzec-holder">
  </div>
  <div id="om-eolfqu9qmzz8cf4nutls-holder">
  </div>
  <div id="om-t3eiyrhf9erdseinbvzd-holder">
  </div>
  <div id="om-alyyzl7q79go6ztivn19-holder">
  </div>
  <div id="om-d49j51fcw2n6jxo1zoay-holder">
  </div>
  <div id="om-vrdk0moqf7opsmqizdoq-holder">
  </div>
  <div id="om-skuj76rdhc0dolwm4amg-holder">
  </div>
  <div id="om-jh9skvhodvs6gl8nq0cw-holder">
  </div>
  <div id="om-va3wsvs2ptpmzfrpm3uu-holder">
  </div>
  <div id="om-ay2zqytt1eg7mfta1ldh-holder">
  </div>
  <div id="om-attpqdc0h87podwklwer-holder">
  </div>
  <div id="om-xh3euetksiiru7ao1i4r-holder">
  </div>
  <div id="om-ryxottsm9ttm84dnwnve-holder">
  </div>
  <div id="om-ocyszdepkcosrp4ezawq-holder">
  </div>
  <div id="om-swwkqmas1kr62suzsjgc-holder">
  </div>
  <div id="om-gjbjwafmepj8oyf0uh1c-holder">
  </div>
  <div id="om-xrckd4n23tcke3xnvlig-holder">
  </div>
  <div id="om-uzph7ru3mebpydv4juas-holder">
  </div>
  <div id="om-k5wwiv6bgkzqkk1lnfaa-holder">
  </div>
  <div id="om-akn2xmbepdt0mzee7l3y-holder">
  </div>
  <div id="om-rlafol0gskqxssksxlti-holder">
  </div>
  <div id="om-grhmrpkchumjuzfppirq-holder">
  </div>
  <div id="om-kpqi02y0ey3cfdn7y92w-holder">
  </div>
  <div id="om-k2u0en5evar87vdbtzyp-holder">
  </div>
  <div id="om-tfe1umqhsv5sky2ahkfe-holder">
  </div>
  <div id="om-ikg5m9ictf3i0sg4jcw5-holder">
  </div>
  <div id="om-qizlzbi0hvbi1tqd4mkm-holder">
  </div>
  <div id="om-rjhnvs1gu4wcbb57rsmv-holder">
  </div>
  <div id="om-jfnn4ohblyn3osxsglzx-holder">
  </div>
  <div id="om-tzrkyu4vrbt2lhttzvhz-holder">
  </div>
  <div id="om-qmwqhpgacll1bbpfviuo-holder">
  </div>
  <div id="om-ih3xmte1xpjtimpg3gba-holder">
  </div>
  <div id="om-urdyzzj6x8etchg5jx1d-holder">
  </div>
  <div id="om-eblhryylamtetlqoq0t7-holder">
  </div>
  <div id="om-oihniipxqd1ijch4tqxu-holder">
  </div>
  <div id="om-tzrgml7oppy1guiatxnq-holder">
  </div>
  <div id="om-rjtgzwwfvyamysmln6oi-holder">
  </div>
  <div id="om-vvfcslsp9oxalcqhjnf3-holder">
  </div>
  <div id="om-rx9uyfbzb7gbnxvrmglf-holder">
  </div>
  <div id="om-wysnbpegqnx5nnbnxulx-holder">
  </div>
  <div id="om-nnrlhdbjetbujxfublpk-holder">
  </div>
  <div id="om-s9agte9yixopobkxamfm-holder">
  </div>
  <div id="om-w86pg4ptz9phapbirdan-holder">
  </div>
  <div id="om-m9h54pllbtfpwguvtzhj-holder">
  </div>
  <div id="om-xjlpujoxtc2otdvvosvq-holder">
  </div>
  <div id="om-fkod41n0xckitem7ebi5-holder">
  </div>
  <div id="om-h5kijeqh38x1vxmupxox-holder">
  </div>
  <div id="om-aj51atevrt5bc2iwlknt-holder">
  </div>
  <div id="om-uljtvrshtjh3q60zm1ho-holder">
  </div>
  <div id="om-cqanbqy7cdrqujxguk3d-holder">
  </div>
  <div id="om-atk9csozxwngdcvi3nqi-holder">
  </div>
  <div id="om-wexx2miywxakb7zkz1ti-holder">
  </div>
  <div id="om-cr0such2nng9qjozrwo8-holder">
  </div>
  <div id="om-umbesemrnlea0xqar1ak-holder">
  </div>
  <div id="om-s2davszhz3dggofphup0-holder">
  </div>
  <div id="om-kyihm8xp5roc3d4ibwex-holder">
  </div>
  <div id="om-zdrpew9jyx04q1z3cusm-holder">
  </div>
  <div id="om-dp2ilwg7hylfykj65wgi-holder">
  </div>
  <div id="om-rlkgnpbb5s0vtmrii4gy-holder">
  </div>
  <div id="om-wxysjjr1l78qmo3umpjf-holder">
  </div>
  <div id="om-aig2icnsdqwakujm1pv9-holder">
  </div>
  <div id="om-p1efofizw1juwiubvzx7-holder">
  </div>
  <div id="om-vaq41xjdfycsttlrnire-holder">
  </div>
  <div id="om-hnxhmfirbapave9ojixu-holder">
  </div>
  <div id="om-vxhtnfe8nepenzqxocx2-holder">
  </div>
  <div id="om-gaar0fyxpw2a0kn8rvda-holder">
  </div>
  <div id="om-grc13byx5otpvumjkye8-holder">
  </div>
  <div id="om-yor6aiesvelg8riqbeyj-holder">
  </div>
  <div id="om-tqf3a6d7jdhde3wgjdwy-holder">
  </div>
  <div id="om-ky0cso0mebbigeojwfbl-holder">
  </div>
  <div id="om-k9tktztstcz73kuxun3s-holder">
  </div>
  <div id="om-ozwqttjklwpoasoyyr0l-holder">
  </div>
  <div id="om-krlqxqs6v9cbnfawp32q-holder">
  </div>
  <div id="om-g2eja7a5g43db8t9m5zg-holder">
  </div>
  <div id="om-g3zkhxgk7tonmhfirxol-holder">
  </div>
  <div id="om-bznef65uvknlczsqzzxw-holder">
  </div>
  <div id="om-sdnfpdzijt02bnhkgsxs-holder">
  </div>
  <div id="om-se9us5yyzov51fvhqw2n-holder">
  </div>
  <div id="om-rldqdhpozyulx8otgmvy-holder">
  </div>
  <div id="om-ma61hhziqsuqxdiyt8uf-holder">
  </div>
  <div id="om-vmqlj4wiwqqyh14ganp5-holder">
  </div>
  <div id="om-an1u4rffdczjbbvozula-holder">
  </div>
  <div id="om-gcwirrw9xk085manaamk-holder">
  </div>
  <div id="om-xjt6e3tt81sw3luoxqsc-holder">
  </div>
  <div id="om-dxlt7swbtgdpmw4opa32-holder">
  </div>
  <div id="om-p3ghosfwdni2u9ajo9lf-holder">
  </div>
  <div id="om-vyrjx2hdbgkciae9nan2-holder">
  </div>
  <div id="om-k23jvc77xebis9dje3fj-holder">
  </div>
  <div id="om-y8ykphc0rvl7aisqne6z-holder">
  </div>
  <div id="om-cebbxjlcufbrj5hf7t59-holder">
  </div>
  <div id="om-l6znjwifi9rgawekfuyc-holder">
  </div>
  <div id="om-pwqfk91efyqve2zkibyf-holder">
  </div>
  <div id="om-ft3l9btpujyc9cot3aio-holder">
  </div>
  <div id="om-oyeffsmz48ycdgd986sm-holder">
  </div>
  <div id="om-f7pjuzzhwjmjqjjwzdoy-holder">
  </div>
  <div id="om-lqswwxibthfkcahsbt9e-holder">
  </div>
  <div id="om-v6xlz7lrpwz0owzgysfh-holder">
  </div>
  <div id="om-nhbohwyrpq4d3uljl631-holder">
  </div>
  <div id="om-acfuk2uppxiglyn7xctg-holder">
  </div>
  <div id="om-wme45w3vgkccljazcpa4-holder">
  </div>
  <div id="om-mjwzcmvskq8fow5klxop-holder">
  </div>
  <div id="om-at6yej3vebyc09lfj8cl-holder">
  </div>
  <div id="om-hmzpm8zjgnpipsyiyb8o-holder">
  </div>
  <div id="om-wdiniuv8smttjndvjtz0-holder">
  </div>
  <div id="om-jf5ydqcvndd2lf21braa-holder">
  </div>
  <div id="om-rqkpovpl6woxamswd4au-holder">
  </div>
  <div id="om-voqkmichfzh7oehgiiep-holder">
  </div>
  <div id="om-s3vnaysezyu1dwabvsci-holder">
  </div>
  <div id="om-msvreea6bdofvdwznw2i-holder">
  </div>
  <div id="om-crwvph7t7mf4fdwyhh4c-holder">
  </div>
  <div id="om-zlyi92cgqjpa5pfnzaxp-holder">
  </div>
  <div id="om-bnzsze3nssx41zdpmiww-holder">
  </div>
  <div id="om-inuc11r7vtb0hptrszec-holder">
  </div>
  <div id="om-w76madvnzz2deiqcmc8k-holder">
  </div>
  <div id="om-oumzv76indhjkncnzcgo-holder">
  </div>
  <div id="om-xmasiydwcuswr7olt4r2-holder">
  </div>
  <div id="om-as1uuhxvuxmtsbeb19py-holder">
  </div>
  <div id="om-hru8ksvox94cqcgirpo1-holder">
  </div>
  <div id="om-bjekvaj1teavesa4angv-holder">
  </div>
  <div id="om-hilqpgizpv2ffcvhk1uu-holder">
  </div>
  <div id="om-j9cgxsev4hbxddoqvj3w-holder">
  </div>
  <div id="om-zy5nmxau0juedd3xckkg-holder">
  </div>
  <div id="om-tl6a2jcytvhirfeajxe9-holder">
  </div>
  <div id="om-w806nuqet9aeeavvwjr9-holder">
  </div>
  <div id="om-qi1ek413owtadtixav3u-holder">
  </div>
  <div id="om-xoutva7rmgolsspdx5vd-holder">
  </div>
  <div id="om-lirebnzvq3gxmnmaknhx-holder">
  </div>
  <div id="om-b4pxwcxknar4nldqetsw-holder">
  </div>
  <div id="om-ofiuz0in1pk1n83uvp4f-holder">
  </div>
  <div id="om-sxd8coy6hx1zor27skxw-holder">
  </div>
  <div id="om-nsrbwhzxwwuelbz8pagf-holder">
  </div>
  <div id="om-u1q5wbwuwsedxm2rokud-holder">
  </div>
  <div id="om-fh2yrmmrpwf7kr6fsqja-holder">
  </div>
  <div id="om-go9h6qa518x4rt6gxlx2-holder">
  </div>
  <div id="om-yke9zix8q6ke2wfavxtm-holder">
  </div>
  <div id="om-nuutzbqzlsqlmjl4ixrx-holder">
  </div>
  <div id="om-uxjde647ojge2lsjzyrv-holder">
  </div>
  <div id="om-fsndh9pgghsjcbkzgawi-holder">
  </div>
  <div id="om-hpq6sqgwjjihvpezlwhm-holder">
  </div>
  <div id="om-wje71lz2jptqsui15oeo-holder">
  </div>
  <div id="om-dwmk9cnpo7ftgf1movgd-holder">
  </div>
  <div id="om-cxlb6klebutvhekv4h1b-holder">
  </div>
  <div id="om-mg07es5ptu9ghvjpmil9-holder">
  </div>
  <div id="om-hrwutdcb3h0qxzzxxela-holder">
  </div>
  <div id="om-fm5qhogbgwcxepylv1wi-holder">
  </div>
  <div id="om-jk0m6oscr1u5z84ku7ec-holder">
  </div>
  <div id="om-rstewme8ntkef62gzabo-holder">
  </div>
  <div id="om-xaye3fwvzjjlvskqybxh-holder">
  </div>
  <div id="om-nc1bw94oalfb6rxsz1pd-holder">
  </div>
  <div id="om-ieu44eq7jlcx5rrtsjz6-holder">
  </div>
  <div id="om-d5z00jq1ssgsc24zlhfr-holder">
  </div>
  <div id="om-rar7to82xh91y5vwprf4-holder">
  </div>
  <div id="om-ruvyq0orgyh6roahqhez-holder">
  </div>
  <div id="om-g75udvcastj2idjw7pdc-holder">
  </div>
  <div id="om-nxu8hl4cp0b1mrlqjngh-holder">
  </div>
  <div id="om-vnzdal9d8ckl0riocrxp-holder">
  </div>
  <div id="om-ffi78b3krmiptskw52n2-holder">
  </div>
  <div id="om-hqmapqsn61gq1p94b1ky-holder">
  </div>
  <div id="om-cbo6lmr29etfstmfp5r9-holder">
  </div>
  <div id="om-oxw4qgazqoy5jx7o61pd-holder">
  </div>
  <div id="om-q5aujptpryuikhhitxfh-holder">
  </div>
  <div id="om-owpvvqwzp4gqbwzvxehp-holder">
  </div>
  <div id="om-lvgh5qilj7fxwzfye0jl-holder">
  </div>
  <div id="om-lmtipqtohqlwmdon82w5-holder">
  </div>
  <div id="om-lz3a36vxkqos8r30uh6p-holder">
  </div>
  <div id="om-yxepwygwh3n5jwjvsklp-holder">
  </div>
  <div id="om-bo7ehy5rlakwcc6x5urc-holder">
  </div>
  <div id="om-y9txfsbxrltlzepykdoz-holder">
  </div>
  <div id="om-zvgddl2adkhp5znmllqm-holder">
  </div>
  <div id="om-da4cx0kcj9b2i01p9hii-holder">
  </div>
  <div id="om-m1pw0q2dmempj5ql6w31-holder">
  </div>
  <div id="om-ykhndsbili40jzp9vbcz-holder">
  </div>
  <div id="om-vh9t6pxmucgfl9fjztbj-holder">
  </div>
  <div id="om-hl7cmexikjgrddtcyvlb-holder">
  </div>
  <div id="om-mx0abkmzcbdhdqsti5fs-holder">
  </div>
  <div id="om-htxswfduywtjjapgufbr-holder">
  </div>
  <div id="om-odwnuqtwvlhmqgklydpk-holder">
  </div>
  <div id="om-mpxg0dff55sns9ahwmmr-holder">
  </div>
  <div id="om-jflu957njlp9pby0mwfv-holder">
  </div>
  <div id="om-tjntfqr4zzhjoifwfnod-holder">
  </div>
  <div id="om-i8vgcpce9xwsbzxncp27-holder">
  </div>
  <div id="om-g3695anuump8nq6afxyw-holder">
  </div>
  <div id="om-dxdbadbqlwhgbo92eyb8-holder">
  </div>
  <div id="om-kn0wluftepy2rr5tc21n-holder">
  </div>
  <div id="om-n7dgsnlteaoni6rzybtm-holder">
  </div>
  <div id="om-mz2nfrj2epw3zqt5s2a8-holder">
  </div>
  <div id="om-tz7wwkkbchprpyovwo8t-holder">
  </div>
  <div id="om-vqxzsjuggykx9yfyfqrq-holder">
  </div>
  <div id="om-ztvdwwwgowxuznxv1wcv-holder">
  </div>
  <div id="om-zfwadfdszkrc98qmj1eg-holder">
  </div>
  <div id="om-mti4ofkb2qevcmozevvu-holder">
  </div>
  <div id="om-f0lpgwatpr45lvykwvtp-holder">
  </div>
  <div id="om-il0uecr5ktdf3nwr83rv-holder">
  </div>
  <div id="om-ckshikovxrenhxpawnv8-holder">
  </div>
  <div id="om-okcbxuiqf9jwi7re50yh-holder">
  </div>
  <div id="om-o0veurrxigeswzk7yktf-holder">
  </div>
  <div id="om-l8yhddneg4leyvrvtbpw-holder">
  </div>
  <div id="om-vswxgyes1c5hszzehogk-holder">
  </div>
  <div id="om-vzjclqwrm0xgpyo1coih-holder">
  </div>
  <div id="om-wwmujxtjbzbwholdpzzb-holder">
  </div>
  <div id="om-qnu5pbip8drtwgpkqprc-holder">
  </div>
  <div id="om-zfwv2zsjui5yuzhkicuw-holder">
  </div>
  <div id="om-a3rd05t4r5lrksmx7b8m-holder">
  </div>
  <div id="om-mjvuabo701tmtc5grmm0-holder">
  </div>
  <div id="om-pjhjfhm4pm6owgnuxim9-holder">
  </div>
  <div id="om-u2ushrsczjtpqtkia7oz-holder">
  </div>
  <div id="om-ue0qa6cwtwrwwwttkuxd-holder">
  </div>
  <div id="om-oa2ity266ftmpzrw3khb-holder">
  </div>
  <div id="om-ajyjep8dfbkewbtly4me-holder">
  </div>
  <div id="om-iyfrnoek7rzfq3cwou2z-holder">
  </div>
  <div id="om-cya86muj0xuujkx3p07j-holder">
  </div>
  <div id="om-psf6dwuljwtllbuvcthv-holder">
  </div>
  <div id="om-qetle24jr2ktpjg3tj1h-holder">
  </div>
  <div id="om-r932stoxftqdcjudyzxh-holder">
  </div>
  <div id="om-mihpqhala8qog9frkkkp-holder">
  </div>
  <div id="om-eb7fpkxybnrkmvsix9pc-holder">
  </div>
  <div id="om-c3nihg15su2jmmyc4wpl-holder">
  </div>
  <div id="om-ilt9uhk4ftinmyls7rck-holder">
  </div>
  <div id="om-aionjv2sros7ys7iun8k-holder">
  </div>
  <div id="om-gt9ar7nmc6x7au2dixaa-holder">
  </div>
  <div id="om-grhaqtgnpedelnhcd9he-holder">
  </div>
  <div id="om-lqozgpqildfgojnrd91i-holder">
  </div>
  <div id="om-ix385jbqwe26ur6urtpu-holder">
  </div>
  <div id="om-fdiyed7mwfsydolxzyno-holder">
  </div>
  <div id="om-enq8p3ae0knwuouwrxen-holder">
  </div>
  <div id="om-wuxjlaqshmeougbbm8nc-holder">
  </div>
  <div id="om-md0b7fndm5lqxiio3f1g-holder">
  </div>
  <div id="om-ekp47at2tu87xxh6sffp-holder">
  </div>
  <div id="om-pl8h7owa3ftgylm4vxpr-holder">
  </div>
  <div id="om-lejwizkrxqw4uhianyj1-holder">
  </div>
  <div id="om-tzwcuvrpnqy2aeqhb4my-holder">
  </div>
  <div id="om-p0e6s90edy5gxtbj6ynm-holder">
  </div>
  <div id="om-nrgx2qhxmebpicgxpxga-holder">
  </div>
  <div id="om-jn1cix1kewyuogplmgjj-holder">
  </div>
  <div id="om-wqcgmbjsirmbbyndeaz8-holder">
  </div>
  <div id="om-t6maex0e8lqvlulohq1n-holder">
  </div>
  <div id="om-enxakdsgadqubvqr8ass-holder">
  </div>
  <div id="om-y6qeug7jqexoc4jszknq-holder">
  </div>
  <div id="om-dnhtqe46bnejuvl6jo4s-holder">
  </div>
  <div id="om-hq9wbzmxo3169hlsdjcj-holder">
  </div>
  <div id="om-wldo9c0ocw9fybviimsx-holder">
  </div>
  <div id="om-p8rphkuhsf37avf2pmgz-holder">
  </div>
  <div id="om-nr8phbr58kjajdaql9da-holder">
  </div>
  <div id="om-ctpkolf9a03vpjnbfx7a-holder">
  </div>
  <div id="om-ouyhyq0o2z6g4dczl91y-holder">
  </div>
  <div id="om-lheitns0sghpnwyeiuas-holder">
  </div>
  <div id="om-zcbq5t07bnyqern37ajv-holder">
  </div>
  <div id="om-oeyr3xogudyeirowts8s-holder">
  </div>
  <div id="om-axjgmptwvhw4p4hcszlx-holder">
  </div>
  <div id="om-kvyhvpkpqubsdosy4nq6-holder">
  </div>
  <div id="om-bfoenhr1fdajpuiwqcii-holder">
  </div>
  <div id="om-hnvvux8ieas4to7lkgn9-holder">
  </div>
  <div id="om-xmpzoblqo8pzehfg4gyw-holder">
  </div>
  <div id="om-gjvqd0msledljgbdhuzt-holder">
  </div>
  <div id="om-pb7h1vlf6bmule1mjgpf-holder">
  </div>
  <div id="om-ddopae3gufmfhks300lf-holder">
  </div>
  <div id="om-o7mvcdkfbnzfxhufjdct-holder">
  </div>
  <div id="om-vyoefm4b6m0epf6va9g1-holder">
  </div>
  <div id="om-fyfam7nsm9juyhzl5wra-holder">
  </div>
  <div id="om-zumtcoew1t9gnvx982j4-holder">
  </div>
  <div id="om-tjawpputgye6yvjkusph-holder">
  </div>
  <div id="om-hfdr3tzkffcbm4ysdxle-holder">
  </div>
  <div id="om-qhtb46onx5vf15qpq7yf-holder">
  </div>
  <div id="om-gal85obgzhp3wwrwtmed-holder">
  </div>
  <div id="om-z4jmmvokahyrc3dwjucs-holder">
  </div>
  <div id="om-ljhprfgtmzwrmxxdrlim-holder">
  </div>
  <div id="om-s16hbhsw69hfixlzcjri-holder">
  </div>
  <div id="om-azxi7tuwy151hrighprx-holder">
  </div>
  <div id="om-s7rapks7ygp9a0pjhqfn-holder">
  </div>
  <div id="om-nyld3karqv70nyldomns-holder">
  </div>
  <div id="om-vdqp7cd9wko3ioocxwnu-holder">
  </div>
  <div id="om-yz7e0ipeo0igml2qtx9i-holder">
  </div>
  <div id="om-jvc53aipecweerdvr4qi-holder">
  </div>
  <div id="om-im5bmgglcr7w0qoqq2le-holder">
  </div>
  <div id="om-zvwhgvvlmvx2gbry21pj-holder">
  </div>
  <div id="om-tt4gqytrnmo6hkflmxwb-holder">
  </div>
  <div id="om-u78zbxe4bhgxz2zv2jsd-holder">
  </div>
  <div id="om-cnitn5jtfwrbi2ru20xa-holder">
  </div>
  <div id="om-nlufkyibzobl6uyoykrn-holder">
  </div>
  <div id="om-ubiyhtzmm56cohftxzwh-holder">
  </div>
  <div id="om-ugwpf76lddtciict3bjl-holder">
  </div>
  <div id="om-y4fslomjwsili74fxanb-holder">
  </div>
  <div id="om-ui3it10tv9gzm6bga7m8-holder">
  </div>
  <div id="om-rppvs48tsw0etp1ag4lv-holder">
  </div>
  <div id="om-nhsgs3ctonfddabkc4by-holder">
  </div>
  <div id="om-pgos5fdprcs2qdpplwlu-holder">
  </div>
  <div id="om-l2ecu2qraijvwimyiepu-holder">
  </div>
  <div id="om-jswtd29xc0ouqhhnerpr-holder">
  </div>
  <div id="om-j6sqg8noolbv7084pkyq-holder">
  </div>
  <div id="om-jszezxw5ogbqfto38ban-holder">
  </div>
  <div id="om-vcycogwvdktkb8tq9pko-holder">
  </div>
  <div id="om-jkdxafj2v3tti6unn8pt-holder">
  </div>
  <div id="om-utejwe7if8jrrlixwlf2-holder">
  </div>
  <div id="om-wihfmafyav42v6ebxjcc-holder">
  </div>
  <div id="om-w5qmsd6h0zqsluldx2au-holder">
  </div>
  <div id="om-fvi8cjpjzkquew1sjltm-holder">
  </div>
  <div id="om-axztyqoxrvhps8yzrvcu-holder">
  </div>
  <div id="om-cmxoo1r0aq7bmsfstfsz-holder">
  </div>
  <div id="om-wn62ngpfignxbad0f0kx-holder">
  </div>
  <div id="om-h24mygclwr6pfk4saywm-holder">
  </div>
  <div id="om-xppyfggrte6tphpt4da5-holder">
  </div>
  <div id="om-hwtdgf2txc3kn08hg8yc-holder">
  </div>
  <div id="om-trdijikv7pkbzdzwux0k-holder">
  </div>
  <div id="om-vf73yg9vzj2fjy4jtcaz-holder">
  </div>
  <div id="om-u5qw72uaw3efms2ylehd-holder">
  </div>
  <div id="om-kiy6vseydjcyzp8ej1py-holder">
  </div>
  <div id="om-rpk06w0wgvb6giepnqof-holder">
  </div>
  <div id="om-ozl3k9gaq1da22cf0t5y-holder">
  </div>
  <div id="om-u7picxd3rcgorpbwylch-holder">
  </div>
  <div id="om-i7hzx46ecmrnxnp0tpxb-holder">
  </div>
  <div id="om-zhpujnbuzcrobiemzn3a-holder">
  </div>
  <div id="om-mip5scukb0cn3z8dpsco-holder">
  </div>
  <div id="om-m7zuq0vcerhyjmi5mbgo-holder">
  </div>
  <div id="om-b6xikje3t5u8rmfcdpja-holder">
  </div>
  <div id="om-cve7n81j7gabiqpmmfze-holder">
  </div>
  <div id="om-ewyybpleuey061ap2qba-holder">
  </div>
  <div id="om-icmr0v7cfr44bzrxfgnv-holder">
  </div>
  <div id="om-novunevcbzsqcsyplzan-holder">
  </div>
  <div id="om-hod9khmsrt4nddvgkpdc-holder">
  </div>
  <div id="om-jbci5nmshpdrwyhxvupc-holder">
  </div>
  <div id="om-gkzfg3zzemggo2ozokn7-holder">
  </div>
  <div id="om-ixxgcqzley1v7d0u5ala-holder">
  </div>
  <div id="om-g2dflwlye75pv50vpoev-holder">
  </div>
  <div id="om-wbrbprbjxzicum5e3hid-holder">
  </div>
  <div id="om-uv7rxelw660pck8vrbh4-holder">
  </div>
  <div id="om-xc9adq5rzbbubebue3ov-holder">
  </div>
  <div id="om-jqxp9edf0pqol2j93t8g-holder">
  </div>
  <div id="om-skplgzrtmwxm1a0d6oze-holder">
  </div>
  <div id="om-lyt7we7344x5x3unierm-holder">
  </div>
  <div id="om-vxncht3mmumkksoeer39-holder">
  </div>
  <div id="om-mcu3apgo8ceweeevam1l-holder">
  </div>
  <div id="om-dlm3qco8ygdzfigbxo23-holder">
  </div>
  <div id="om-myqr4dgwripprt5kxtvc-holder">
  </div>
  <div id="om-ln6bjrctf1biv3zuiwdh-holder">
  </div>
  <div id="om-bedriqxitwpn0fpnanrs-holder">
  </div>
  <div id="om-yhrfdoru0jecuz6cd3pj-holder">
  </div>
  <div id="om-qzwlkgw9witxxzgkrquh-holder">
  </div>
  <div id="om-lvnjcaqwpxkap2ywvkei-holder">
  </div>
  <div id="om-cfq5eig6r0lqhykkyext-holder">
  </div>
  <div id="om-ybcywthekcgimhevjkkw-holder">
  </div>
  <div id="om-p0rhisnxky6hjhpwkltw-holder">
  </div>
  <div id="om-ruqdhtmi0y661246imkt-holder">
  </div>
  <div id="om-lcnbypeg7hc3s2z0sbsk-holder">
  </div>
  <div id="om-pbb0rezy4butlt5ttgoy-holder">
  </div>
  <div id="om-gjkdxlvid1fu7nywtqbg-holder">
  </div>
  <div id="om-kpm6dkn5okznxmxybpz8-holder">
  </div>
  <div id="om-kmiip9hd5l4dmufkdsjm-holder">
  </div>
  <div id="om-xz8h7sjuzjzzwhdlaqhl-holder">
  </div>
  <div id="om-xwgjkvwabpdzycsgynfx-holder">
  </div>
  <div id="om-r4j79zz1bdhqtbcoehy8-holder">
  </div>
  <div id="om-xipcnmk68iyfkbhchmuf-holder">
  </div>
  <div id="om-qlrlwuapczty8ab8strc-holder">
  </div>
  <div id="om-ad5jehopexltoywlf34r-holder">
  </div>
  <div id="om-khup84v2lsjd2bwmgitb-holder">
  </div>
  <div id="om-wgunm3zj7fbveubrkzjy-holder">
  </div>
  <div id="om-dm8hr8wdjxyteal6vntb-holder">
  </div>
  <div id="om-xesf7yyirrt7hzbealkf-holder">
  </div>
  <div id="om-yn4qw9nc7lbedx0uiiqp-holder">
  </div>
  <div id="om-xh9xrvss8ysioj5nchce-holder">
  </div>
  <div id="om-yhimtokgzyysgtqnlwh7-holder">
  </div>
  <div id="om-po5aqzivwzhewleoxezr-holder">
  </div>
  <div id="om-hujkmnuczivz1pj6mpqi-holder">
  </div>
  <div id="om-y7akyysbhv7xzfewhiaw-holder">
  </div>
  <div id="om-tp5u31soi78gpopyes26-holder">
  </div>
  <div id="om-zszbzskac6spwgcaft12-holder">
  </div>
  <div id="om-zfrq7kac9fvzrhxos9rk-holder">
  </div>
  <div id="om-umc0gmrydilnfyfxf7ux-holder">
  </div>
  <div id="om-dmmrb4vkezqwmaalua1u-holder">
  </div>
  <div id="om-a7x5skfpgmplrg0xqg9h-holder">
  </div>
  <div id="om-to7mmralatbksg5cmvws-holder">
  </div>
  <div id="om-xxwgefiujswijmwpxpci-holder">
  </div>
  <div id="om-ibatxxepxq8itgk2eyln-holder">
  </div>
  <div id="om-nyo4ewu5ozlny8zpjrwq-holder">
  </div>
  <div id="om-rlqelsipwtvmquvfzimg-holder">
  </div>
  <div id="om-vbasj7xe8klujrtcdhe2-holder">
  </div>
  <div id="om-sub7q8ezyjrj5z3l2cfh-holder">
  </div>
  <div id="om-k7rqgngax1bjbu3znguv-holder">
  </div>
  <div id="om-xeg6fokomtffpxn5ltyx-holder">
  </div>
  <div id="om-me8o718zro4tfnwvym9n-holder">
  </div>
  <div id="om-yx3tlzgk4gbvevunm9ic-holder">
  </div>
  <div id="om-rahpv3h823unhuno9i6j-holder">
  </div>
  <div id="om-umcdd8siyppksz5eoshb-holder">
  </div>
  <div id="om-wy41a7ocdwvvqtdpv2vf-holder">
  </div>
  <div id="om-aharflwy7iqu81ohgqe7-holder">
  </div>
  <div id="om-hwc9acumknlurrisif40-holder">
  </div>
  <div id="om-dtdz5ohoteq73n4qhgzn-holder">
  </div>
  <div id="om-w0gha7zfz4q2jxtdjtvq-holder">
  </div>
  <div id="om-ve0qrvf9x061ibyxkn2c-holder">
  </div>
  <div id="om-hllwb9apkhxfeuvd6hgb-holder">
  </div>
  <div id="om-crgjhvwrp0voxepupu6j-holder">
  </div>
  <div id="om-hp6mo8d5q6mpiqvts06g-holder">
  </div>
  <div id="om-pniolsx0s5ctehriegw1-holder">
  </div>
  <div id="om-gumom0slqf1cwamv3yx9-holder">
  </div>
  <div id="om-yviru8xk6lotionwolbu-holder">
  </div>
  <div id="om-pnhg5amgaicdoshp9xvt-holder">
  </div>
  <div id="om-r8nuwmlvtsrmkhil9nky-holder">
  </div>
  <div id="om-k7f2ivoum7imxecqx4tc-holder">
  </div>
  <div id="om-qep8cxwssw6vbw2fad7g-holder">
  </div>
  <div id="om-topqvkkhijtxxqzejd9k-holder">
  </div>
  <div id="om-tzqwhtqazvhf3cwfbivx-holder">
  </div>
  <div id="om-mypl4p8n281zuyxpru2u-holder">
  </div>
  <div id="om-emvvny1mdw4pionjztt1-holder">
  </div>
  <div id="om-c0hz1tynme37zmbtuslc-holder">
  </div>
  <div id="om-scycj5vz2veqckd7af6m-holder">
  </div>
  <div id="om-kvbrjsrozesbkjji063x-holder">
  </div>
  <div id="om-vryflsw0inndpos2nqmp-holder">
  </div>
  <div id="om-hhnvlfd0ave1qkmtql5z-holder">
  </div>
  <div id="om-qtj4wbbx6quekro74noc-holder">
  </div>
  <div id="om-maw1nujgfi3lfyrxwi6q-holder">
  </div>
  <div id="om-rnmvygkspt589g42bpab-holder">
  </div>
  <div id="om-htegebfybks8qvahi4h2-holder">
  </div>
  <div id="om-nr4pr3a85tgmnuxu4rbu-holder">
  </div>
  <div id="om-cr3j0avyratrvnmgqadz-holder">
  </div>
  <div id="om-s9tsubeolfsib8hy5ej6-holder">
  </div>
  <div id="om-ihnttarbtkl3rs2xqp1p-holder">
  </div>
  <div id="om-krjn8v3wootnpeubpk0c-holder">
  </div>
  <div id="om-xc8bxokqnpml3dwosmri-holder">
  </div>
  <div id="om-cnlc3ebxczo0znbdogeo-holder">
  </div>
  <div id="om-mlxkqh9d50rrzuwpr2gz-holder">
  </div>
  <div id="om-swha5dmnhc8vzxg8m2pa-holder">
  </div>
  <div id="om-vyaawj2p07q0jrdystob-holder">
  </div>
  <div id="om-c3uu5daigxyqo4yiphcu-holder">
  </div>
  <div id="om-u4e0zzvmiadaqlhn2ez9-holder">
  </div>
  <div id="om-zzd3zakfrbajyqus7tme-holder">
  </div>
  <div id="om-dgaqk3b3dcab17pfehp0-holder">
  </div>
  <div id="om-sgsaxmt7itiv9dlhzvo4-holder">
  </div>
  <div id="om-pyndzbc6illavcp5wslu-holder">
  </div>
  <div id="om-rbdtuarxois9tehjwems-holder">
  </div>
  <div id="om-kjtab4ckbwcoq2fkurim-holder">
  </div>
  <div id="om-rzzabnn9e2tfu9faludl-holder">
  </div>
  <div id="om-fosfjaaj8tivawtcudou-holder">
  </div>
  <div id="om-dtwrbrfncmet3fugyf9r-holder">
  </div>
  <div id="om-hwxplanzn7upjfnieu6t-holder">
  </div>
  <div id="om-vmnw8tlwvqoiboqj8pnt-holder">
  </div>
  <div id="om-rsjfaxip1tzfw1sepkno-holder">
  </div>
  <div id="om-cavksk1lelokjoubrlah-holder">
  </div>
  <div id="om-f9u2x7mtj8onojyjglun-holder">
  </div>
  <div id="om-axiapztewjnactzowlui-holder">
  </div>
  <div id="om-app35gphrqeqj5ujcl1h-holder">
  </div>
  <div id="om-ouagvjlf3spfffhycjv8-holder">
  </div>
  <div id="om-wlfugvsfb22ivxotmzag-holder">
  </div>
  <div id="om-gskmdwjchw0fo2iyvqxp-holder">
  </div>
  <div id="om-rvhtc1aulihmxrc0cl23-holder">
  </div>
  <div id="om-hlhm3ggt6m0szi0e4bwr-holder">
  </div>
  <div id="om-z4ftjpxy5rdjrs8boy2b-holder">
  </div>
  <div id="om-b8oekken4tv3mleunqo8-holder">
  </div>
  <div id="om-bfynuvhbqvoy8v6ozbni-holder">
  </div>
  <div id="om-m2etiztgc4u6mnbbdi7w-holder">
  </div>
  <div id="om-pquavrz3vmixilkcebox-holder">
  </div>
  <div id="om-zln5wftw3hi9a46y3r69-holder">
  </div>
  <div id="om-avrmv6ya0solme0tqgua-holder">
  </div>
  <div id="om-mtoma6hsmthj8txxdhw9-holder">
  </div>
  <div id="om-savc9flu7eczgghu6xrl-holder">
  </div>
  <div id="om-bypprzg1146umyzjuu2s-holder">
  </div>
  <div id="om-tteq3j2gajxkirq2vsld-holder">
  </div>
  <div id="om-d2kh8cc3fwcbiaqdkoms-holder">
  </div>
  <div id="om-c9lwqbjwrtreqmftgihu-holder">
  </div>
  <div id="om-gi4nk8yoktnjeyxn7ivj-holder">
  </div>
  <div id="om-bwyf1ruwbwfvkn2x4siu-holder">
  </div>
  <div id="om-um01sruzkewwxk2euizj-holder">
  </div>
  <div class="fb_reset" id="fb-root">
   <div style="position: absolute; top: -10000px; width: 0px; height: 0px;">
    <div>
    </div>
   </div>
  </div>
 </body>
</html>
